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Biosecurity practices of beef cow-calf herds in western Canada have not been studied 
extensively, and the impacts these practices have on animal health with the herd. The 
association between not implementing good biosecurity practices and herd health in cow-calf 
herds is not well understood.  This study used a survey of 103 cow-calf producers who were 
part of the Western Canadian Cow-Calf Surveillance Network. Eighty-one questionnaires were 
returned. The questionnaire asked about current cattle inventory, other animals on the farm 
(dairy cattle and other species), purchased animals, source of purchased cattle, procedures 
done to purchased cattle (i.e. disease testing and vaccinations), commingling with other herds, 
management of people and equipment, and biosecurity within the herd. There were also 
questions about the incidence of diseases within the herd to determine the impact of 
biosecurity practices on animal health. During the study period of 2014-2017, all the herds 
purchased bulls, 54% of herds purchased heifers, and 42% purchased cows. The use of standard 
biosecurity practices was generally low with 30% of producers keeping purchased animals 
separate and 30% vaccinating new additions. Logistic regression models found that none of the 
biosecurity practices were significantly associated with having Johne’s disease. The purchase of 
10 bulls or more over the four years, and the purchase of any cows from other farms or private 
sales was associated with a higher risk of reporting an outbreak of Bovine Respiratory Disease 
(BRD) in the herd. Not vaccinating animals purchased into the herd and use of community 
pasture also was associated with the risk of a BRD outbreak. Outbreaks of calf diarrhea were 
similarly significantly associated with the purchase of over 10 bulls and use of community 
pasture, as well as leasing and sharing bulls. Biosecurity is not emphasized on cow-calf farms in 
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western Canada and the purchase of adult cattle and using community pasture are risk factors 
for BRD and calf diarrhea. 
Next, was a study to describe the prevalence and antimicrobial sensitivity of 3 major BRD 
bacterial pathogens from auction market derived vs single ranch source calves, at arrival and 
later in the feeding period. The animals enrolled were 299 calves of various beef-type breeds 
derived from multiple auction markets (AUCT) and 300 similar breed-type-calves sourced 
directly from a single ranch (RANCH).   All calves were sampled using a deep nasal pharyngeal 
swab at the time of entry to the feedlot and again at 64 to 168 days after arrival. The swabs 
were cultured within 24 hours of sampling and sensitivity testing of isolates for Mannheimia 
haemolytica (MH), Pasteurella multocida (PM) and Histophilus somni (HS) was performed. In 
the AUCT calves, the prevalence of MH decreased significantly from 38% to 20% (P <0.001), and 
the prevalence of HS increased significantly from 17% to 30% (P = 0.001) between sampling 
events. In the AUCT calves there was an increase in calves with MH isolates not sensitive to 
tulathromycin from 1% in the first sample to 7% in the second.  There was also a significant 
increase in calves with PM isolates not sensitive to florfenicol (from 0% to 3%), oxytetracycline 
(from 1% to 4%) and tulathromycin (from 0% to 3%).  Finally, in the AUCT calves there was a 
significant increase in calves with HS isolates not sensitive to oxytetracycline (from 0% to 12%), 
tilmicosin (from 0% to 10%) and tulathromycin (from 0% to 9%).  In the RANCH calves, 
prevalence of all pathogens decreased significantly throughout the study. From 30% to 20% (P = 
0.01) for MH, from 60% to 43% (P <0.001) for PM and from 40% to 6% (P <0.001) for HS. In the 
RANCH calves there was a significant decrease in calves with MH isolates that were not 
sensitive to oxytetracycline (from 6% to 0%), tilmicosin (from 5% to 0%), and tulathromycin 
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(from 5% to 0%). There was also a significant increase in calves with PM isolates not sensitive to 
florfenicol (from 0% to 9%), oxytetracycline (from 0% to 10%), tilmicosin (from 2% to 14%) and 
tulathromycin (from 0% to 10%). There were few or no isolates not sensitive to ceftiofur or 
enrofloxacin. Antimicrobial resistance of BRD pathogens and prevalence of bacterial pathogens 
can vary over the feeding period differently in calves sourced either from auction markets and 
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1.1.1 Biosecurity Introduction 
Biosecurity in animal agriculture is the outcome of all activities undertaken by a farm, ranch, or 
feedlot personnel to preclude the introduction of disease agents into an area that one is trying 
to protect 1. Herd biosecurity as a concept has existed in North America since the eradication of 
Contagious Bovine Pleuropneumonia from the United States in the late 19th Century 1. Most 
formal biosecurity programs that cattle producers and veterinarians have become involved in 
up to the present time have been organized or mandated by government agencies1. Two of the 
earliest examples in Canada were the tuberculosis and brucellosis control programs. In these 
early cases, biosecurity was mandated at a national level, not the farm or individual herd level. 
However, for both programs, there was conviction that producers’ and public’s needs were 
best served by control of these diseases. In 1951-1952, Foot and Mouth Disease spread rapidly 
in Saskatchewan2, and in 2003 the first case of Bovine Spongiform Encephalopathy was 
diagnosed in a cow that was born in Canada3. More recently bovine tuberculosis was diagnosed 
in 6 cows from a farm in Alberta requiring the testing of 34 000 cows4. All these examples have 
highlighted the needed for greater biosecurity measures at both the national and farm level.  
 
In Canada, the number of farms with cattle and calves has steadily dropped from over 225 000 
in 1976 to just over 73 000 today5.  However, the number of cattle in Canada has increased 
slightly over that same time and is now close to 13 million6. With those changes come 
increased purchases of animals, herd consolidation of smaller herds into larger herds, and a 
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greater risk of introducing disease into those herds. The average cow-calf herd in Canada 
increased in size from 74 head in 2011 to 84 in 20167. This trend appears to be accelerating as a 
recent Canadian study showed that the average age of cattle producers is increasing, with an 
increasing rate of retirement8.  However, in comparison to the feedlot industry, the average 
cow-calf herd size is quite small. Over the same period, feedlot operations grew on average 
from 185 head of beef cattle in 2011 to 212 head in 2016 7. When we look at where most of the 
feeding capacity for cattle is, 69% of Canada’s fed cattle production is concentrated in Alberta9. 
In Alberta, there are 149 feedlots with an average annual capacity of 1000 head or higher, and 
together they feed 1.6 million head of cattle9. In Canada, the cow-calf industry is characterized 
by a large number of relatively small cow-calf operations sending cattle through auction 
markets for sale, which are then consolidated into large feedlots to be fed to slaughter.  
 
As a result of the structure of the beef industry, there is significant mixing of cattle that 
promotes the spread of disease and makes effective biosecurity measures very difficult. There 
have been many efforts to reduce this mixing by directly marketing of cattle from the ranch to 
feedlots; however, most cattle are still sold through the auction market where they are co-
mingled into groups for shipment to the feedlot. 
 
It has been previously reported that 75% of emerging diseases originate from domestic or wild 
animals and 60% of existing human infectious diseases are zoonotic10. The risk to human health 
from diseases that originated in animals in substantial.  Biosecurity is therefore not only 




1.2.1 Current Biosecurity Practices in Beef Cattle Herds 
The current study investigated the biosecurity practices of beef cattle herds in western Canada. 
This has not been studied in detail to the knowledge of the author, and the information that 
exists is mostly in other areas of the world, such as the European Union, and in other areas of 
animal agriculture, such as the swine and poultry industries. 
 
There has been a number of studies investigating biosecurity practices on beef cattle farms in 
other countries, particularly in the European Union11–15.  This type of research is lacking in 
North America. Biosecurity in beef cattle can be very different than biosecurity practices that 
are common in other areas of animal agriculture. Exclusion biosecurity is a strategy aimed at 
preventing the introduction of disease agents by not allowing contact between the animals you 
are trying to protect and other animals. Typically, this is achieved using a barn or fences and not 
allowing new additions to be introduced until they have been quarantined and tested. In beef 
cow-calf herds, it is not possible to practice total exclusion biosecurity, due to the extensive 
nature of how beef cattle are raised and exclusion from other cattle and wildlife in open ranges 
is often not feasible. As well, the segmented nature of beef production in Canada necessitates 
that cattle are often bought and sold between herds and moved from cow-calf herds through 
auction markets to backgrounding lots and finally to finishing feedlots prior to slaughter. Within 
the backgrounding lots and finishing feedlots, almost all cattle are sourced from other farms 
and mixed either prior to or at the time of arrival. As a result, exclusion biosecurity is usually 
not possible, and this creates multiple opportunities for disease introduction and transmission. 
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This is very different from the situation in poultry and pig farms, where the movement of 
people and animals into and out of a barn is often more tightly controlled12,16. 
 
In general, cattle farmers’ knowledge about biosecurity is low16. In a survey of Belgian cattle 
farmers, only 2.1% were able to give a fully correct definition of biosecurity compared to 8.2% 
of pig and poultry farmers. Over 15% of cattle farmers could only give a partially-correct 
definition of biosecurity and 83% could not give a correct definition at all16. Despite not being 
able to give a definition of biosecurity in the same survey, 85% of cattle farmers felt their own 
knowledge of biosecurity was average or above average. This disconnect between cattle 
producers’ perceived knowledge and actual knowledge may create an environment where 
learning about biosecurity seems unnecessary.  
 
In any animal facility, biosecurity relies on five stages17 (i) Bio-exclusion: limiting the risk of 
introduction; (ii) Biocompartmentation: limiting the spread within the same facility; (iii) 
Biocontainment: limiting the spread to other animal facilities (inter-herd transmission); (iv) 
Bioprevention: preventing human contamination; and (v) Biopreservation: preventing 
environmental contamination with potential pathogens. Other terminology is sometimes used 
such as biocontainment instead of biocompartmentation and biosecurity instead of bio-
exclusion18; but the meaning is the same. In current beef production systems in North America 
the utilization of these stages is limited. The following paragraphs will describe in more detail 
bio-exclusion and biocompartmentation. 
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1.2.2 Bio-exclusion: limiting the risk of introduction 
Bio-exclusion is often referred to as external biosecurity. In the U.S. Department of 
Agriculture’s National Animal Health Monitoring System (NAHMS) study conducted in 2007–08, 
67.8% of all beef cow-calf operations had added new cattle to the herd in the previous 3 
years19. In the same study, 30.7% of herds purchased, leased, or borrowed bulls for the 
previous breeding season. As well, 29.4% of operations had more than 10 visits per month from 
visitors (employees, neighbors, veterinarians, etc.) and only 17.9% of operations had no visits. 
Animal movement and human movement into beef cow-calf herds is a very common event and 
presents a very real risk for disease introduction.  
 
As mentioned before, by nature, beef feedlots cannot exclude disease as the cattle are not born 
on site. In the U.S., 58% of feedlots source over half of the cattle in the feedlot from auction 
marts and not directly from farms18. This increases the number of sources from which the cattle 
are coming and increases the potential for disease introduction. In the same study only 14% of 
feedlots required trailers to be cleaned prior to loading incoming cattle and only 2% of visitors 
were required to wear clean boots or foot coverings when visiting the feedlot.   
 
1.2.3 Biocompartmentation: limiting the spread within the herd 
Biocompartmentation is also often known as internal biosecurity. In the U.S. Department of 
Agriculture’s National Animal Health Monitoring System (NAHMS) study conducted in 2007–08, 
66.3% of cow-calf operations did not quarantine new arrivals to the herd, exposing the rest of 
the herd to any diseases the new arrivals might carry19. Another strategy to reduce the spread 
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of disease from new arrivals is to test them for any diseases they may be carrying. In the 
NAHMS study only 4.5% of herds tested for Bovine Viral Diarrhea Virus (BVDV) and 5.4% tested 
for Bovine Tuberculosis. 
 
The situation is similar in other parts of the world. A survey in the United Kingdom found that 
59% of cattle farmers had recently brought cattle onto the farm, and although 70% did ask 
about previous disease history, 73% either never or only sometimes isolated cattle arriving onto 
the farm11. Less than 30% of farmers took preventative measures with newly introduced cattle 
such as vaccinations, anthelminthic protocols, or testing for diseases such as tuberculosis. 
Other studies show similar results in Australia20, Finland12, Belgium15 and Ireland21. 
 
Personal hygiene (cleaning and disinfecting of boots and clothing) is also not routinely 
practiced.  In the UK study mentioned above, only 7% of farmers carried out personal hygiene 
such as boot washing or changing coveralls when moving from one management group to the 
next11. 
 
A survey of feedlots in the U.S found that 37% of the feedlots allowed fence-line contact 
between sick animals and healthy animals18. Also, 25% of feedlots used the same equipment to 
handle dead cattle, manure, and feedstuffs, with only 14% of those feedlots cleaning the 
equipment between uses. Transmission of agents with a fecal-oral route of spread such as 
BVDV, Escherichia coli O157, and Salmonella spp. may be facilitated by this practice18. Less than 
half of feedlots cleaned processing and treatment facilities on a daily basis18. 
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1.3.1 Biosecurity Practices in Other areas of Animal Agriculture. 
As mentioned previously, other areas of animal agriculture use much different biosecurity 
methods than beef cattle herds. Dairy cattle would have the most similar practices, with the 
key difference being that dairy is more vertically integrated; replacements and production 
animals more often exist in the same herd.  However, in one study, 44% of dairy producers had 
purchased new cattle and introduced them to the herd in the previous 3 years22. In the same 
study, the most common type of cattle purchased were lactating cows, which would have the 
highest disease risk to a dairy herd due to opportunity for exposure to disease pathogens such 
as those that cause mastitis22.   
 
Hygiene appears to be better on dairy farms, but still low with 43% of dairy producers changing 
boots and 39% wearing gloves when working with sick calves in one study23. Testing of new 
arrivals for diseases such as Johne’s disease (Mycobacterium paratuberculosis) is higher in dairy 
herds as well at 18%22.  
 
In swine production, practices such as not allowing visitors to enter the barn freely and 
requiring visitors to wear clothing specific to that barn are commonplace – over 85% of barns in 
one study24. Very similar results are seen in Swedish25 and Finnish12 studies. Entry rooms to 
allow for the changing of clothes are common as well26. In almost every study comparing 
biosecurity measures on pig farms to beef cattle farms, swine producers have more stringent 
standards in controlling disease entry and spread12,25. Swine producers also commonly use a 
practice known as all in/all out where a section or the entirety of the barn is emptied of animals 
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then cleaned and disinfected before a new groups of pigs is introduced26. This practice is 
virtually nonexistent in cattle farms.  
 
1.3.2 Motivators for Improved Biosecurity 
It is important to look at what motivates producers to implement improved biosecurity 
practices on their farms. In one study, the top 3 reasons for implementing biosecurity practices 
by cattle producers were to improve profit due to higher productivity, to have farm stability 
(the absence of disease outbreaks), and to improve animal welfare16. However, research in 
Denmark has demonstrated that even legislation on biosecurity plans does not lead to 
implementation if there is no perception of benefits27. Farmers seem to be strongly motivated 
by what is their standard practices, and generally only implement those measures that they 
understand and know the most about28. Biosecurity practices that are based on local 
knowledge of disease are more likely to change farmers behaviors than standardized 
practices29. In a study of pig farmers looking at both endemic and epidemic diseases, farmers 
valued on-farm biosecurity measures as a significantly more effective risk management strategy 
than animal health programs30. When looking at the risk of actual diseases, the majority of the 
farmers (68.9%) implemented biosecurity measures to manage animal disease risks on their 
farms whereas only 35.6% farmers participated in animal health programs with the same 
purpose30. The animal health programs in that study involved the producers learning more 
information about the diseases.  
 In a questionnaire to Belgian cattle farmers 46.5% of the farmers were convinced of the 
positive effect of biosecurity. Very few farmers (0.9% of the cattle farmers) indicated that they 
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thought biosecurity had no influence at all on the reduction of diseases16. Another concept is 
the idea of being a “good farmer”. Farmers take pride in their work and a strong motivator for 
having good biosecurity was to appear to others that they were doing a good job31,32. Farmers 
tend to be very independent and this trait seemed to come out in the research as well. A 
Danish study on the control of Johne’s disease showed that motivation to participate in a 
voluntary control program came primarily from not only hoping to improve animal health but 
also a wish to be certified free of Johne’s disease33. However when biosecurity controls are 
imposed on farmers by government, there seems to be much less willingness to cooperate34. 
 
A study by Cardwell et al. looked at the impact of tailored biosecurity advice given to farmers by 
their veterinarians versus more generic advice about biosecurity, and how that impacted their 
behavior related to biosecurity. In both cases, biosecurity practices on the farms improved, but 
there was a trend towards even greater biosecurity improvements when the advice was 
tailored to a specific farm35. 
 
1.4.1 Barriers to implementing biosecurity measures 
Many studies have asked the question – “What is holding farmers back from instituting 
biosecurity measures?” A Belgian study found that the most important reason for not 
implementing more biosecurity measures was that it is too expensive and too much work. 
However, the second most common response was that there was nothing holding them back 
from implementing greater biosecurity16. A lack of knowledge or understanding of biosecurity 
principles among farm employees and visitors has already been proposed as another reason for 
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poor biosecurity36. Poor biosecurity compliance may also be related to an unwillingness to 
comply and intentional errors seem to be related to beliefs and attitudes36.  
 
There is wide variations in recommendations for biosecurity practices and some producers may 
not comply due to confusion37. The cost of implementing biosecurity measures has a strong 
influence on farmers willingness to implement them38. Economics are also an influence38 with 
farmers needing evidence of effectiveness before implementation39. There is also a need to 
build trust amongst stakeholders20,39,40. There seems to be a feeling that responsibility for 
biosecurity and the costs of it should be shared by government and industry. However, 
government involvement can have the opposite effect to that which is desired. In the United 
Kingdom where there have been recent outbreaks of Foot and Mouth Disease (FMD) and 
Bovine Spongiform Encephalopathy (BSE), 58% of cattle and sheep farmers felt that the most 
desirable biosecurity measures were having none at all. They also felt that the least useful 
measures were those imposed on them by the government during the FMD outbreak34.  
 
1.5.1 Sources of Information on Biosecurity 
Many studies have looked at where farmers get their information on biosecurity. The number 
one source in a number of studies is the herd veterinarian34,41,42. The other most common 




1.6.1 Biosecurity and Prevention of Disease 
Purchase of new livestock when the incoming animals remain in contact with the recipient herd 
for an extended period of time presents the highest risk for introducing infectious hazards43. 
Bringing in new livestock as infrequently as possible and taking appropriate precautions – 
quarantine, vaccination, disinfection, etc. – is the most effective way to use biosecurity to 
prevent disease. In a study of Dutch dairy farms, farms that purchased cattle and/or shared 
pasture (termed as 'open' farms) differed in performance from farms that did not ('closed' 
farms). The results showed that the 'closed' farms incurred lower costs for veterinary services, 
and had a lower average age at first calving and a higher birth rate per 100 dairy cows. Being 
'closed' was found to increase the net profit by approximately £25 per cow per year at the time 
of the study or 5 per cent of the typical net return to labor and management44. 
 
Much of the current literature describes the current practices that exist in various agriculture 
industries when it comes to biosecurity. However, there is much less relevant research on the 
role of biosecurity in preventing disease – especially when it comes to beef cattle. The most 
relevant research to the current study was done by Waldner et al. on over 200 beef cow-calf 
herds in 2001 and 2002. Their research looked at different management aspects of cow-calf 
production, with some of these related to biosecurity. They found that cows bred on 
community pastures were more likely to be pregnant and less likely to have an abortion if they 
had been previously vaccinated for BVDV and BHV1. Cows bred on community pastures that 
were not vaccinated were less likely to be pregnant and more likely to abort than those that 
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were not bred on community pastures regardless of vaccination status45,46. Aspects of 
biosecurity such as mixing from communal grazing seems to play a role in abortion and non-
pregnancy. 
1.6.2 Biosecurity and Bovine Tuberculosis. 
A study in England and Ireland on the spread of bovine tuberculosis found that increasing the 
contact time with potentially infected cattle increased risk of contracting bovine tuberculosis. 
In Ireland, up to 25% of bovine tuberculosis cases were attributed to spread from herds on 
adjacent farms. Farms with a neighboring infected herd were almost four times as likely to have 
a bovine tuberculosis case47. Bringing new animals into the herd is also a significant risk factor 
for bovine tuberculosis in a number of studies47–49. Introduction of bovine tuberculosis to a 
herd is strongly associated with cattle movements48. Gopal et al. found that purchased animals 
were the most likely source of bovine tuberculosis in 30 out of 31 herds49.  
 
1.6.3 Biosecurity and Bovine Viral Diarrhea Virus (BVDV) 
A well-documented way to introduce BVDV into a herd is through the purchase of transiently or 
persistently infected cattle50. Other risk factors for having BVDV seropositive animals in a herd 
are herd-to-herd contact across pasture fences, using common pastures, and acquiring 
insufficient information about BVDV status in purchased animals50. Another study 
demonstrated that importing pregnant animals and youngstock have the greatest impact on 
increasing the financial risks from BVDV, while strategic testing and vaccination programs have 
the most impact on decreasing the risk of herd outbreak of BVDV51. In a Scottish study, for 
every log10 increase in number of beef cattle moved onto a farm, the odds of being seropositive 
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for BVDV increased by a factor of 3.2152. Cattle movements (purchasing of cattle onto the farm) 
have 3 times greater explanatory power for BVDV seropositivity than local spread risk factors 
(disinfection, double fencing, shared pastures, visitors on farm)52. Tailored biosecurity advice to 
individual farmers has been shown to have a significant impact in decreasing BVDV 
seropositivity in beef herds35. 
 
1.6.4 Biosecurity and Bovine Herpes Virus - 1 (BHV-1) 
A study on Dutch dairy farms showed that direct animal contacts with other cattle (i.e. allowing 
cattle to return to the farm when not successfully sold and grazing cattle at other farms) 
increased the risk of BHV-1. As well, professional visitors such as the herd veterinarian should 
be required to wear protective clothing provided by the farmer before they handle cattle, as 
this was also a risk factor for BHV-1 infection53.  Implementation of general biosecurity 
practices in beef herds in England and Wales decreased the seropositivity to BHV-1 after 2 
years14.  Finally, Dias et al. found that buying in cattle, renting pasture from other farmers and 
use of a bull were risk factors for BHV-1 infection54. 
 
1.6.5 Biosecurity and Mycobacterium avium subspecies paratuberculosis (MAP) 
In dairy herds with greater than 25% of replacement females purchased and brought into the 
herd, the risk of having a cow test positive for MAP in the herd increased by an odds of 2.155. If 
a producer purchased cattle in the last 5 years the odds of having MAP was 3.1 times higher56. 
In dairies, allowing calves to be exposed to the feces of adult cattle increased the odds of MAP 
in a herd by over 30 times55. In a western Canadian study, purchased replacement beef heifers 
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had a 2.3 times higher odds of being MAP positive57. Restocking after herd depopulation and 
importation of animals have also been associated with MAP infection58,59. 
 
1.6.6 Biosecurity and Digital Dermatitis (DD) 
In a study on digital dermatitis in dairy cattle, poor external biosecurity measures associated 
with higher prevalence of DD were recent animal purchase, access to pasture, lack of boots 
available for visitors, farm staff working at other dairy farms, hoof trimming without a 
professional attending, and animal transporters having access to cattle area60. For biosecurity 
within the herd, digital dermatitis was more prevalent in herds with infrequent foot bathing, 
manure scraping less than 8 times a day, manure removal direction from cows to heifers, the 
exits from animal pens not being equipped with water hoses, manure-handling vehicle used in 
other activities, and water troughs contaminated with manure60.  
 
1.6.7 Biosecurity and Disease Prevention in Other Species 
There has been some interesting research in the prevention of disease using biosecurity in 
other species.  In pigs, Laanen et al. showed that improved external (measures to keep disease 
out of the herd) and internal (measures to prevent the spread of disease in the herd) 
biosecurity resulted in improvements in daily weight gain and feed conversion61. They also 
found that as biosecurity improved there was a decreased use of antibiotics for prophylaxis61. A 
case control study conducted during the outbreak of Classical Swine Fever in the Netherlands in 
1997 showed increased risk of infection in herds that had commercial poultry on the farm, did 
not require visitors to wear boots and coveralls provided by the farm, and where truck drivers 
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did not wear boots from the farm62. Elbers et al. demonstrated that hygiene precautions such 
as changing boots and coveralls in between farms are very important in the transmission of 
Classical Swine Fever62.  
 
Firestone et al. found in the equine influenza outbreak in Australia in 2007 that having a 
footbath in place, improved hygiene precautions such as hand washing and changing clothes 
and shoes, and the farm being located greater than 5km from an infected premises helped to 
prevent influenza infection63,64. 
 
1.7.1 Bovine Respiratory Disease (BRD) 
Bovine Respiratory Disease is the most significant disease of beef cattle in North America and 
the most common cause of morbidity and mortality in cattle feedlots65. The primary bacterial 
pathogens associated with BRD are Mannheimia haemolytica, Pasteurella multocida, and 
Histophilus somni. As well, viral pathogens discussed earlier such as BVDV and BHV-1 are often 
associated with BRD.  Overall, an estimated 21 percent of cattle placed in feedlots show signs of 
respiratory disease at some point during the feeding period and 4 percent of these die as a 
result65. Bovine Respiratory Disease accounts for 70-80% of all morbidity in feedlots and 40-
50% of the mortalities66. As well, despite numerous advances in vaccine use, newer 
antimicrobials and other advances, the incidence of BRD has not declined since the 1990’s66. 
Cattle with respiratory disease have reduced feed intake, require treatment with 
antimicrobials, and as noted above, can die as a result of the disease, making respiratory 
disease very costly to the feedlot industry. Annual global losses due to respiratory disease are 
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estimated to be around $3 billion67. Surveys of cow-calf producers indicate that bovine 
respiratory disease in preweaned beef calves is recognized on approximately 20% of operations 
and in the US, BRD is reported to be the leading cause of death in calves 3 weeks of age up to 
weaning68. 
 
The pathogens associated with BRD are enzootic in the general cattle population so attempts to 
eliminate the pathogens are impractical69. Biosecurity in the feedlot is especially difficult as 
cattle are sourced and mixed from many farms18. Instead, feedlots attempt to limit the spread 
of BRD through practices such as metaphylaxis (treating entire groups of cattle with 
antimicrobials on arrival), vaccination, separating sick animals and placing them in hospital 
pens, controlling the spread of diseases that potentiate the effects of BRD pathogens such as 
BVD virus, and reducing commingling of cattle by sourcing cattle from a limited number of 
farms69. 
 
1.8.1 Cattle source and impact on bovine respiratory disease 
There have been many attempts to reduce morbidity and mortality due to BRD by changing the 
risk factors in calves arriving at the feedlot. The management term “preconditioning”, which 
has been around since the mid-1960’s, has been proposed as a method to reduce morbidity 
due to BRD. Preconditioned calves are typically vaccinated, weaned, dehorned, dewormed, 
castrated, and trained to eat from a bunk prior to entry into the feedlot70. Multiple studies have 
shown that preconditioning reduces morbidity and mortality due to BRD in the feedlot70–72.  
Preconditioning implies some knowledge on the source and management history of the calves 
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prior to being moved into the feedlot. The source of calves also influences morbidity and 
mortality due to BRD in the feedlot. Step et al. showed that ranch-origin calves were less likely 
to be treated for BRD than auction market-derived calves, and calves that were weaned 45 days 
prior to feedlot entry also were less likely to be treated71. Richeson et al. showed markedly 
greater morbidity for auction market (86%) versus preconditioned (4%) calves during a 14-d 
study period73. In that study, the auction market calves also required a second treatment with 
antibiotics more often (33% versus 4% for the preconditioned calves)73. 
 
1.9.1 Antimicrobial treatment of BRD 
Antimicrobials are commonly used to help control and treat BRD in high-risk feedlot cattle. The 
term high-risk can have many definitions but generally these calves are light weight, recently 
weaned, highly commingled, of auction market origin, or a combination of these things66. 
Additionally, they generally have experienced an extended duration of transport and have an 
unknown health and vaccination history74. Since 1988, a number of new antimicrobial agents 
have been approved to treat BRD67. These include ceftiofur, tilmicosin, tulathromycin, 
florfenicol, enrofloxacin, danofloxacin, gamithromycin, and tildipirosin. This new suite of 
antimicrobials has transformed the treatment of BRD in feedlots by offering both superior 
efficacy to previous drugs, as well as greater ease of use due to the extended duration of action 
of many of them.  
 
Many of these drugs have label claims for metaphylaxis to prevent and treat early cases of BRD 
in feedlot cattle. Metaphylaxis is the treatment of an entire group of cattle with an 
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antimicrobial intended to control BRD in highly stressed, newly received calves75. Metaphylaxis 
has been shown to consistently reduce morbidity and mortality in feedlot cattle through a 
number of studies75–78, and for that reason, its use is widespread in the feedlot industry75,78. A 
recent meta-analysis of 58 publications showed a combined relative risk of 0.49, indicating a 
substantial reduction in morbidity from metaphylaxis78.  
 
1.10.1 Measures of Antimicrobial Resistance 
Antimicrobial resistance of BRD pathogens can result in treatment failures and losses 
associated with increased treatment costs, the need to retreat calves, and mortalities. In a 
recent review article looking at 16 publications, the authors stated “there appears to be a clear 
trend of a decrease in susceptibility of the three major BRD pathogens to the antimicrobials 
used commonly for treatment and control of BRD”79. There is also the concern that 
antimicrobial resistant genes could be transmitted to people80–84.  Resistance genes to 
antimicrobials not used in humans have been found in bacteria that are zoonotic to humans 
such as salmonellae, and in pathogens only found in humans such as shigellae83.  This would 
suggest there is a risk that genes that are resistant to antimicrobials used to treat BRD could 
transfer to humans. 
 
Antimicrobial Sensitivity Tests (AST) are the most used method to determine the sensitivity of a 
particular pathogen to an antimicrobial drug. The Clinical Laboratory and Standards Institute 
(CLSI) provides the most commonly used standards to determine if an organism is susceptible 
to a particular antimicrobial drug. Minimum Inhibitory Concentrations (MIC) provide the most 
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used standard for determining if an antimicrobial is active against a pathogen in vitro. The MIC 
is the lowest dose of an antimicrobial drug that prevents visible growth of a bacteria. The two 
most commonly used systems to determine MIC are agar dilution and broth microdilution, with 
broth microdilution being the most popular due to the availability of commercial kits67. Agar 
dilution involves combining 2-fold dilutions of an antimicrobial drug with agar media and then 
plating a standard concentration of bacteria onto each plate, followed by observing the lowest 
concentration of antimicrobial where bacterial growth still occurs85. This is a labour-intensive 
process which is why the more automated broth microdilution process is more commonly used. 
The microdilution system contains doubling dilutions of the antimicrobial agent in broth. Each 
dilution is inoculated with a standardized bacterial suspension and incubated for 18 to 24 
hours85. The first dilution with no visible growth is considered the MIC for that bacteria.  
 
It can be very challenging to extrapolate the MIC of an antimicrobial drug determined using this 
process to the clinical efficacy that would be observed in the field. Factors such as how 
advanced disease was at the time of treatment, health status of the animal, as well as 
pharmacokinetic and pharmacodynamic parameters need to be considered67. For example, 
certain antimicrobials such as florfenicol and tulathromycin achieve higher concentrations in 
lung tissue than in plasma, which could affect the clinical efficacy86. 
The MIC values can be used for individual cases to help determine if an antibiotic is likely to be 
effective against a particular BRD pathogen. However, an MIC value for an individual case of 
BRD can take many days to obtain, so it is necessary to choose an antimicrobial for treatment 
prior to having this information. Often the MIC50 and MIC90 values are used to guide empirical 
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therapy. These values represent the levels at which 50% and 90% of strains in a bacterial 
population are inhibited67. If the MIC50 and MIC90 are low for an antimicrobial against a 
particular BRD pathogen, one can be relatively certain that there is not significant resistance 
and that the therapy is likely to be effective. 
 
1.10.2 Determination of Clinical Efficacy 
To determine if an antimicrobial will be effective in a clinical setting, information about 
microbiologic distribution, pharmacokinetic and pharmacodynamics, and outcome data from 
clinical efficacy trials needs to be examined85,87. In North America, this is done by the CLSI to 
establish breakpoints for a bacterial isolate. A CLSI-approved veterinary breakpoint is 
established by looking at a number of factors such as the disease being treated, type of 
bacteria, animal, and antimicrobial treatment. In this way, a BRD isolate can be classified as 
susceptible, intermediate or resistant. A susceptible isolate would be expected to be affected 
by treatment with the chosen antimicrobial, and a resistant isolate would be expected to be 
unaffected, resulting in treatment failure. Intermediate is a transitional zone where the 
treatment may work or fail depending on factors such as dosage and local drug concentrations. 
The actual response is, of course, dependent on a number of other factors such as immune 
status of the animal, stage and severity of the disease when the animal is treated, and actual 




1.11.1 Current Antimicrobial Resistance in Bovine Respiratory Disease Pathogens 
The following section looks at the known resistance to each class of antimicrobial used to treat 
BRD in bacterial pathogens that are commonly associated with BRD. 
 
1.11.2 Tetracycline Resistance 
The first report of tetracycline resistance in Pasteurella multocida and Mannheimia haemolytica 
is from a study done by Chang and Carter in 197679. They used susceptibility criteria that 
predate current CLSI standards are therefore difficult to compare to current studies. 
The first study published using CLSI standards and microdilution methods to look at MIC 
distributions consistent with the methods used today was published by Watts et al. in 199488. 
They looked at isolates from animals that had died of acute BRD over a four-year period from 
1988 to 1992.  There were high levels of resistance to tetracycline in the P. haemolytica isolates 
tested with a MIC90 of 32.0 µg/ml (the breakpoint used was 4 µg/ml) for all 4 years and only 
57% of the isolates were susceptible. There was significant resistance found in P. multocida as 
well with only 71.1% of isolates being susceptible. The compound was more active against H. 
somni with 98.2 % of isolates susceptible. Welsh et al. looked at antimicrobial resistance in BRD 
pathogens isolated from lung samples collected during necropsy of calves with pneumonia 
submitted from 1994-2002. They found a significant decline in susceptibility to tetracycline in P. 
multocida isolates over that time period89. Portis et al. conducted a 10-year study from 2000-
2009 looking at the major BRD pathogens collected from diagnostic laboratories across the 
United States and Canada. The samples were all from diseased and deceased calves, but there 
was not any information on age or previous treatment history. All of the antimicrobial 
22  
  
susceptibility testing was done according to current CLSI standards at only 2 laboratories, to 
keep results consistent. They found high resistance rates to tetracyclines among M. 
haemolytica isolates with only 48-53% being susceptible over the 10 years90. Similar results 
were found with P. multocida with around 54-67% of isolates being susceptible. Interestingly, 
the susceptibility of H. somni appeared to change over the course of the study with over 80% of 
isolates susceptible in 2000 and 2001, dropping to 47% in 2009. 
 
Tetracycline has the highest levels of resistance from BRD pathogens of any of the 
antimicrobials. It is not entirely clear why this is, although it may be due to the fact that it has 
been in continuous use for the longest time, as well as the fact that it has highest frequency of 
use by a significant margin91. The United States Food and Drug Administration reported in 2015 
that tetracycline drugs account for two-thirds of the antimicrobials used for the prevention of 
BRD91. 
 
1.11.3 Macrolide Resistance 
The macrolide class of antimicrobials are used extensively in the treatment of BRD, particularly 
for metaphylaxis92. Currently approved macrolides used commonly for metaphylaxis include 
tilmicosin, tulathromycin, gamithromycin and tildipirosin. Two of the earliest available 
macrolides used for BRD treatment were erythromycin and tilmicosin and they were first 
examined for antimicrobial resistance from 1988 - 1992 by Watts et al. Tilmicosin has been an 
important drug for metaphylaxis since 1990 in Canada and surprisingly they encountered 
significant resistance in that early study to the BRD pathogens. Only 69.1% of M. haemolytica 
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isolates obtained from the lungs of cattle that died of BRD were susceptible to tilmicosin over 
the four years and only 58.9% of P. multocida were susceptible93. Interestingly, in the same 
study isolates from Canada were much more susceptible, in the 90-100% range for BRD 
pathogens93. It was speculated whether these results were due to extensive use of 
erythromycin in the United States and not Canada, thus conferring cross resistance in the more 
affected population. Other Canadian based studies have shown similar results. Several 
Canadian studies have shown almost no resistance to tulathromycin in M. haemolytica 
isolates94–96. However, Timsit et al. found resistance to tulathromycin (71.8%) and tilmicosin 
(79.5%) to be high97 in research done in western Canada. A project from 2015 had similar 
findings suggesting that the Canadian resistance patterns may be changing to match those in 
the United States98. 
 
1.11.4 Fluoroquinolone Resistance 
Currently, there are three fluoroquinolones that are approved for use in the treatment of BRD: 
enrofloxacin, danofloxacin, and marbofloxacin. In the United States, fluoroquinolones are 
prohibited for extra-label use99. In Canada, the label for Baytril 100 (enrofloxacin) states the 
following, 
 “To limit the development of antimicrobial resistance: Baytril 100 should not be 
used as a mass medication for cattle and swine. Baytril 100 should only be used 
for treating individual cases of bovine and swine respiratory disease after first 
choice treatment has failed. The choice of Baytril 100 as the most appropriate 
treatment should be confirmed by clinical experience supported, where possible, 
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by pathogen culture and drug susceptibility testing. Do not use in an extra-label 
manner in cattle, swine or any other species100.” 
 In Canada, this label is unique in its restrictions on extra-label use and recommendation for use 
only when a first treatment has failed.  
 
One of the earlier studies looking at susceptibility of BRD to the fluoroquinolones was done by 
Welsh et al. and showed high susceptibility to enrofloxacin in both M. haemolytica (89–98% 
susceptible) and P. multocida (96-100% susceptible) isolated from the lungs of calves that died 
of BRD89. The Portis et al. 10-year study ending in 2009 found that the number of M. 
haemolytica isolates from BRD cases susceptible to enrofloxacin decreased from 95% to 80%90. 
Similarly, susceptibility of P. multocida to enrofloxacin dropped from 100% to 91% and H. somni 
from 100% to 86%90. The Portis et al. study concluded that while a “majority of BRD isolates 
that were tested between 2000 and 2009 demonstrated susceptibility to danofloxacin and 
enrofloxacin, there was a slow decline in the percentage of isolates that were susceptible90.” 
 
1.11.5 Phenicol Resistance 
The only antimicrobial approved for the treatment of BRD from this family is florfenicol. 
Chloramphenicol was used extensively in the treatment of BRD up until the early 1980’s when it 
was banned due to human safety concerns67. Florfenicol has been for approved for the 
treatment of BRD since the mid 1990’s. Florfenicol achieves high concentrations in the 
pulmonary fluids, with levels at 200% of plasma levels reported86. The earliest survey reporting 
antimicrobial resistance to florfenicol was published by Welsh et al. (2004). Their research 
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showed a significant decline in antimicrobial sensitivity to florfenicol in M. haemolytica and P. 
multocida but no change in H. somni in the period from 1994 to 200289. Portis et al. found there 
was close to a 10% decrease in susceptible isolates from 2000 to 2009, from 100% down to 
around 90% for all three major BRD pathogens90.  
 
This increasing level of resistance to florfenicol in the major BRD pathogens is supported by 
recent studies in the United States. Lubbers and Hanzlicek found an increase in M. haemolytica 
resistant isolates from 5% to 35% in the years 2009 to 2011 to 5 or more antimicrobials, with 
florfenicol being one of those antimicrobials. Snyder et al. found high levels of resistance 
(69.4%) to florfenicol in nasal swabs taken from calves after 10-14 days on feed101.  
In southern Alberta, the area of Canada where the highest number of feedlot cattle are located, 
florfenicol resistance is still low. Anholt et al. found only 4.3% of samples from cattle sick or 
dead from BRD positive with M. haemolytica were resistant to florfenicol98. The levels of 
resistance were below 2% for P. multocida and H. somni. Very low levels of resistance to 
florfenicol were also found by Timsit et al. in the same area of Alberta97. 
 
1.11.6 Beta-Lactam Resistance 
Penicillin and ampicillin have been used for the treatment of BRD for decades; however, today 
with the newer antimicrobials their use has greatly decreased92. Penicillin still accounts for 10% 
of all antimicrobial drugs sold in the United States for all food producing animals, second only 
to tetracycline91. Beta-lactamases produced by M. haemolytica and P. multocida degrade 
penicillin and ampicillin, making them less effective67. Prior to the use of current CLSI criteria, 
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both Chang and Carter102 as well as Post et al.103 found resistance to penicillin and/or ampicillin. 
Watts et al. in 1994 demonstrated high levels of resistance to ampicillin by M. haemolytica 
isolated from calves that died of BRD with only 60% of samples taken over a 4-year period being 
susceptible93. In the same study, for both P. multocida and H. somni there were higher rates of 
susceptibility, around 90%. Interestingly, the survey study over 10 years by Portis et al. ending 
in 2009 showed almost identical rates of susceptibility for penicillin to the 3 major BRD 
pathogens90.  
 
Today, the most commonly used beta-lactam antimicrobial agent for the treatment of BRD in 
North America is ceftiofur. This agent is a third-generation cephalosporin that is unaffected by 
the beta-lactamases produced by M. haemolytica or P. multocida67. Ceftiofur was first 
introduced in the United States in 1988 and was included in the survey by Watts et al. starting 
in 1988. For all 4 years of the study, the 3 major BRD pathogens remained 100% susceptible, 
with a MIC90 of <0.06 µg/ml93. The ten year survey by Portis et al. showed identical results90. In 
fact, ceftiofur is unique in that almost every study of BRD pathogens up to and including the 
present day have a very low MIC90 of less than or equal to 0.06 µg/ml for ceftiofur and 
susceptibilities at or very near 100%67,97,98,101,104. Ceftiofur stands alone as the only 
antimicrobial that has not shown any appreciable increase in resistance since its introduction. 
Health Canada has categorized ceftiofur as a Category 2 antimicrobial of high importance to 




1.12.1 Multi-drug resistance 
Perhaps the most concerning development in the last few years in the area of antimicrobial 
resistance is multi-drug resistance (MDR). MDR can be of major concern in feedlot cattle, as it 
makes it more difficult to find effective antimicrobials to treat BRD. In some areas of the United 
States BRD isolates are being found that are resistant to multiple classes of antimicrobials104,95. 
This is also starting to occur in Canada98. Most of the available research would suggest that 
there is substantial MDR in the tetracycline and macrolide classes of antimicrobials. Lubbers et 
al. found that P. haemolytica isolates from clinical cases of BRD that were resistant to 
oxytetracycline were 3.52 times more likely to be resistant to 1 or more additional 
antimicrobials compared to non-oxytetracycline resistant isolates104. Timsit et al. in a 2016 
western Canadian study found high levels of resistance (>70%) against oxytetracycline in M. 
haemolytica and P. multocida isolated from cattle with BRD and high levels of resistance against 
oxytetracycline (67%) in H. somni isolates97.  When looking at the macrolide class, Lubbers et al. 
showed that isolates from clinical cases of BRD that were resistant to tilmicosin were 2.64 times 
more likely to be resistant to another antimicrobial. Many studies have shown that MDR is 
common with macrolides, and there does appear to be evidence that the level of resistance is 
increasing, particularly in cattle that have already been treated with a macrolide such as in the 
case of metaphylaxis97,98,101,104,106. 
Most research does not implicate the fluoroquinolones as having a significant role in multi-drug 
resistance. A 2017 study by Anholt et al. in Alberta, Canada showed high levels of multidrug 
resistance with 47% of the BRD isolates from dead and diseased calves being resistant to 4 to 5 
antimicrobial classes. However, the fluoroquinolones were only included in a small percentage 
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of those resistant isolates – in the case of enrofloxacin, less than 4% for any of the 3 major BRD 
pathogens98. Other studies have demonstrated very similar findings97,107, however another 
recent study from 2017 showed higher levels of resistance to enrofloxacin, so it is possible that 
these patterns are changing101. Recently, Japanese researchers have observed resistance rates 
in fluoroquinolone antimicrobials to have increased up to 4-fold over the period of 2006 to 
2009, from 4.8% to 18.8%108. Fluoroquinolones have been in use for BRD treatment a decade 
longer in Japan than in North America, which may contribute to this increase109. 
 
1.12.2 Genetic mechanisms of multi-drug resistance 
Recently, Michael et al. found 12 antimicrobial resistance genes within an integrative 
conjugative element (ICE) in an isolate of P. multocida from bovine respiratory tract 
infections110.  An ICE can introduce new DNA into bacteria. This ICE, designated ICEPmu1, 
contains the resistance genes aadA25 (streptomycin/spectinomycin), strA and strB (strepto- 
mycin), aadB (gentamicin), aphA1 (kanamycin/neomycin), tetR-tet(H) (tetracycline), floR 
(chloramphenicol/florfenicol), sul2 (sulfonamides), erm(42) (tilmicosin/clindamycin), and msr 
(E)-mph(E) (tilmicosin/tulathromycin)110. The presence of these 12 resistance genes in a single 
ICE demonstrates the potential for transfer of multiple antimicrobial resistance genes in one 
horizontal gene transfer event110. Klima et al. found M. haemolytica, P. multocida, and H. somni 
in lung samples from cattle in Texas and Nebraska possessing ICE that conferred resistance for 
up to seven different antimicrobial classes95. In their study, 45% of all bacterial isolates 
displayed resistance to three or more antimicrobials. Thirty-three percent of M. haemolytica 
isolates, 37.5% of P. multocida isolates, and 30% of H. somni were resistant to more than seven 
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antimicrobial classes, including aminoglycosides, penicillins, fluoroquinolones, lincosamides, 
macrolides, pleuromutilins, and tetracyclines95. The ability of the BRD pathogens to confer 
resistance to multiple antimicrobial drugs in a single gene transfer is very concerning and could 
severely decrease the effectiveness of the available antimicrobials.  
 
1.13.1 Impact of Antimicrobial Resistance on Clinical Efficacy  
As new antimicrobials have become available over the last thirty years for treatment of BRD in 
cattle, resistance from BRD pathogens has developed to those antimicrobials. Over that same 
time, antimicrobial susceptibility testing (AST) has made it easier to determine which 
antimicrobials are most likely to be effective. However, there are limitations to applying AST to 
clinical outcomes in treating BRD. One of the most significant limitations to AST is that it takes 
several days to get results. This means that clinically the selection of an antimicrobial to treat a 
particular case of BRD or for use in metaphylaxis on a group is based on past experience and 
testing by the clinician, not the actual sensitivity profile of the pathogen being treated.  
Another limitation discussed earlier is the disease state of the animal prior to treatment. 
Clinical scores are often used in studies on antimicrobial effectiveness, and these range from 
slightly ill to moribund74. When lungs are examined at slaughter, 68% of cattle that have signs 
of pneumonia at slaughter were never treated for BRD74. Antimicrobials are only likely to be 
effective if given early in the progression of BRD, and sick animals must be detected by feedlot 
personnel, regardless of the sensitivity profile of the pathogen being treated. Finally, clinical 
efficacy is determined by the susceptibility of the organism to the selected antimicrobial. As 
mentioned earlier, veterinary specific interpretive criteria to help correlate the in vitro test 
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result with clinical outcome that we have today are very helpful. Apley et al. showed that the 
clinical success rate when treating isolates of M. haemolytica categorized as susceptible was 
84.9%. In contrast, the success rate in treating animals with isolates categorized as either 
intermediate or resistance was only 38.9%111. Clinical efficacy often seems to be directly linked 
to in vitro susceptibility testing, although at times this association is not as clear112.  
 
1.14.1 Conclusion 
Finding ways to treat and prevent disease in beef cattle using methods such as improved 
biosecurity and effective treatment methods for BRD is important for the future health of the 
industry. There is a need for more research on biosecurity practices in cattle and their effect on 
animal health. Due to the structure of the Canadian cattle industry, exclusion biosecurity 
cannot be reasonably achieved in beef herds. However, based on the available research from 
other countries, there may be biosecurity actions that can be undertaken to help limit the 
introduction of disease.  Purchasing of new animals into a herd has the greatest negative 
impact on animal health from a biosecurity perspective. Based on that information, limiting 
new introductions into cow-calf herds to a minimum should help reduce disease. Testing the 
newly introduced animals for diseases such as BVD will likely also reduce the transmission of 
certain diseases. Exposure to cattle from other farms also increases the risk so limiting the use 
of community pastures and avoiding fence line contact whenever possible may have health 
benefits. Hygiene practices seem to play a lesser role in disease transmission; however, for 




There is a need to better understand the biosecurity practices that exist on Canadian beef 
farms. This study set out to quantify animal introductions into herds, where and how cattle mix, 
and other aspects of biosecurity in beef production. As well, this study looked at how 
biosecurity practices impact animal health in those herds. By doing so, recommendations can 
be developed to help producers make changes to biosecurity that would have the most benefit 
in improving animal health in their herds.  
 
Over the last thirty years several new antimicrobials have become available to treat BRD in 
cattle, and at the same time resistance to those antimicrobials has increased. Also, it seems 
that the longer an antimicrobial is in use for, the greater the number of resistant isolates that 
are documented. Together, this would lead to the conclusion that over time the control of BRD 
will rely on either the development of newer, more effective antimicrobials, or a change in 
production and management methods so that antimicrobials are not required as frequently. 
Improving biosecurity methods used by cow-calf producers should reduce the need for 
antimicrobials. Changing the source of calves from the auction market to a single source 
reduces mixing and may decrease the need for antimicrobial use as well. Programs such as the 
preconditioning of calves have shown to dramatically decrease morbidity and mortality66. 
Finally, faster testing to allow for susceptibility testing chute-side and appropriate antimicrobial 
selection at the time of treatment through whole genome sequencing is being explored. 




By studying the impact of source and commingling on both the prevalence of BRD pathogens 
and antimicrobial resistance of those pathogens, we hoped to be able to find ways to help 
reduce the use of antimicrobials to control BRD. Does purchasing calves from a single source of 
calves reduce the BRD risk because they are exposed to less pathogens? Or is it the type of BRD 
pathogens that are different? Finally, what impact does antimicrobial resistance have on the 




1.15.1 Objective of Research  
The overall objective of this thesis is to better understand ways to prevent disease in cattle, 
other than using antimicrobials or vaccines.  Several studies have been published recently with 
information coming from the WCCSN. These studies have looked at vaccine usage in western 
Canadian cow-calf herds113 and antimicrobial usage in those herds114.  The focus of this thesis is 
to look at other factors that are associated with cattle health in cow-calf herds and in the 
feedlot.  Factors such as preventing disease from entering a herd through biosecurity, and how 
mixing of cattle in the auction market can impact the BRD pathogens isolated and their 
resistance patterns.  
The first objective of this thesis was to describe current biosecurity practices in cow-calf herds 
in western Canada and examine the potential association of those practices with animal health. 
Specifically, the study examined the association between biosecurity and Johne’s disease, 
bovine respiratory disease, and calf diarrhea in those herds.  
The second objective of this thesis was to look at the effect that source of cattle has on the 
prevalence and antimicrobial resistance of BRD pathogens: M. haemolytica, P. multocida, and 
H. somni. Mixing of cattle through the auction market is suspected of being a major risk factor 
in the development of BRD.  The study examined the BRD pathogens isolated and their 
resistance patterns in single source calves (RANCH) vs auction market derived (AUCT) calves 
that are mixed. As well, the research looked at treatment for BRD and death and the 
association to prevalence and antimicrobial resistance of BRD pathogens. The aim was to better 
understand how source can affect the types of BRD pathogens that are observed, and the 
impact that has on morbidity and mortality in the feedlot. Similar to the first objective, the goal 
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was to find ways to reduce BRD, without necessarily relying on the use of antimicrobials or 




Chapter 2. Biosecurity practices in western Canadian cow-calf herds and their association 
with animal health 
Biosecurity practices of beef cow-calf herds in Western Canada have not been studied 
extensively, nor has their association with herd health.   A survey was sent to 103 cow-calf 
producers with biosecurity and animal health questions. The results showed that certain 
decisions around biosecurity such as purchasing adult animals and community pasture grazing 
are associated with BRD and calf diarrhea in those herds.    
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2.1 Abstract  
Biosecurity practices of beef cow-calf herds in Western Canada have not been studied 
extensively. Neither is there a good understanding of their association with herd health.   A 
survey was sent to 103 cow-calf producers who are part of the Western Canadian Cow-Calf 
Surveillance network.  Eighty-one questionnaires were returned.  Questions were asked about 
current inventory, other animals on the farm (dairy cattle and other species), purchased 
animals, source of purchased cattle, intake management of purchased cattle (i.e. disease 
testing and vaccinations), commingling with other herds, potential risks from people and 
equipment, and general herd biosecurity, as well as disease history.  All the herds purchased 
bulls during the 2014-2017 study period, 54% of herds purchased heifers and 42% purchased 
cows. The use of standard biosecurity practices was generally low with 30% of producers 
keeping purchased animals separate and 30% vaccinating new additions.  None of the 
evaluated biosecurity practices were associated with reporting Johne’s disease. The purchase of 
over 10 bulls and the purchase of any number of cows were associated with an outbreak of 
Bovine Respiratory Disease (BRD).  Not vaccinating animals purchased into the herd and use of 
community pasture were also associated with a BRD outbreak.  Outbreaks of calf diarrhea were 
associated with the purchase of 10 or more bulls, the use of community pasture, as well as 
leasing and sharing bulls. Biosecurity is not emphasized on cow-calf farms in western Canada 
and the purchase of breeding animals and using community pasture are risk factors for BRD and 




2.2 Introduction  
Globally there is a recognized need to reduce antimicrobial drug usage, making prevention of 
disease a top priority particularly as the worldwide demand for beef continues to increase. The 
objective of biosecurity is to prevent new pathogens from entering a livestock operation and 
also to reduce the spread of any existing pathogens within that premises16. 
The beef industry in Canada presents some unique challenges to implementing and maintaining 
adequate biosecurity protocols. There are a relatively large number of cow-calf operations, just 
under 73,0005, concentrated mainly in western Canada. Their production is funneled into a 
small number of feedlots; in Alberta and Saskatchewan there are only 163 feedlots with 
average annual capacity of 1000 head or higher, and together they feed 1.5 million head of 
cattle115. This results in a large amount of mixing of cattle from various farms, often as they 
pass through auction markets on the way to a feedlot. This challenge of the industry structure 
is coupled with uncertainty regarding the level of knowledge about basic biosecurity practices 
among beef producers, consistent with that reported in other countries11,12,15,20,116.  In Canada 
the Canadian Food Inspection Agency has published the Canadian Beef Cattle On-Farm 
Biosecurity Standard, which has recommendations for best practices in biosecurity for beef 
producers117.  It is uncertain to what extent these practices are followed.  There is limited 
information about biosecurity practices in beef cow-calf farms in Canada45,46,118,119. Previous 
research relevant to the current study found that cows bred on community pastures were more 
likely to be pregnant and less likely to have an abortion if they had been vaccinated for Bovine 
Viral Diarrhea Virus (BVDV) and Bovine Herpesvirus Type 1 (BHV-1)45,46.  
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In the  United States, the National Animal Health Monitoring System (NAHMS) found over two 
thirds of cow-calf ranches added new cattle to the herd within the previous 3 years19. As well, 
two thirds of producers did not quarantine new additions to the herd and less than 5% tested 
new cattle for diseases such as BVD and Johne’s19. 
 
Several studies have shown that biosecurity can have an impact on animal health. Cardwell et 
al. found that biosecurity advice tailored to the producer by their herd veterinarian reduced 
seropositivity to BVDV and Leptospirosis hardjo on beef farms in the United Kingdom14. 
Presi et al. has shown that farms that bring in new livestock and use communal summer grazing 
are more likely to introduce BVDV infection into the herd120. Two other studies also showed 
that purchase of new animals into the herd increased the risk of BVDV51,121. Dias et al. found 
that buying cattle and renting pasture from other farmers were risk factors for bovine 
herpesvirus infection54. Bringing new cattle into the herd has been shown to be a significant 
risk factor associated with the presence of bovine tuberculosis47–49. In a western Canadian 
study, purchased animals had a 2.3 times higher odds of being Mycobacterium avium 
paratuberculosis (MAP) positive57.   
 
Similar results can be found in other areas of animal agriculture. In a study of Dutch dairy farms, 
farms that purchased cattle or shared pasture (termed as 'open' farms) differed in performance 
from farms that did not ('closed' farms). The results showed that the 'closed' farms incurred 
lower costs for veterinary services, had a lower average age at first calving, and a higher birth 
rate per 100 dairy cows44. Laanen et al. looked at biosecurity measures in Belgian pig farms and 
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found that increased biosecurity resulted in improvements in daily weight gain and feed 
conversion. They also found that as biosecurity improved there was a decreased use of 
antibiotics for prophylaxis61. 
 
The objectives of this study were to describe current biosecurity practices in cow-calf herds in 
western Canada and examine the potential association of those practices with animal health. 
Specifically, this study examined the association between biosecurity and Johne’s disease, 
bovine respiratory disease, and calf diarrhea in those herds.  
 
2.3 Materials and Methods 
2.3.1 Ethics Statement 
This study was approved by the University of Saskatchewan’s Animal Research Ethics Board 
(#20140003) and the Human Behavioural Research Ethics Board (#14-07). 
 
2.3.2 Herd recruitment 
A biosecurity questionnaire was distributed to 103 cow-calf producers in western Canada 
participating in the Western Canadian Cow-Calf Surveillance Network (WCCCSN) in July 2017. 
One hundred and twenty-three producers had originally been recruited but at the time of this 
study the WCCSN consisted of a convenience sample of 103 cow-calf producers in the Canadian 
provinces of Alberta, Saskatchewan, and Manitoba. The 2011 Census of Agriculture122 was used 
to determine recruitment targets for herd numbers in various geographic regions 
representative of reported herd density. The targeted distribution of moderately sized herds 
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(100-300 cow-calf pairs) and larger herds (>300 cow-calf pairs) were also determined from 2011 
Census of Agriculture data. Local veterinary clinics were asked to assist in the recruitment of 
herds from their clientele. Criteria for recruitment included those clients that were interested in 
participating, herds which routinely pregnancy tested their herd, and producers that kept basic 
production records. Interested producers were paid a yearly honorarium to be part of the 
WCCCSN and were asked to complete approximately 3 surveys per year. 
 
2.3.3 Survey content 
The questionnaire contained the following sections related to biosecurity: current inventory, 
other animals on the farm (dairy cattle and other species), purchased animals, source of 
purchased cattle, where cattle were sold, intake procedures applied to purchased cattle (i.e. 
disease testing and vaccinations), commingling with other herds, potential risks from exposure 
to people and equipment, animal health practices, and general biosecurity within the herd. 
Questions were asked about animal movements onto and off the farm and other sources of 
commingling such as community pastures. Cleaning of tools and equipment was examined, as 
was other common biosecurity practices such as the separation of sick animals from healthy 
ones. The questionnaire also asked about diseases within the herd and antimicrobial use for 
potential associations with biosecurity practices. See Appendix 1 for a copy of the 
questionnaire.  
 
Prior to full distribution, the questionnaire was sent to 5 cow-calf producers who were not 
study participants for pretesting and to gather feedback about the questions and suggestions 
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for improvements in wording and clarity. The questionnaires were distributed in June 2017 to 
the WCCCSN participants who could either fill out a paper copy and return it by mail or 
complete the identical questionnaire online.  
 
2.3.4 Data management and statistical analysis 
Data from the biosecurity survey were collected and entered into a commercial spreadsheet 
program (Excel 2017; Microsoft Corp., Redmond, Washington, USA). One producer was 
removed from the analysis because of incomplete survey data. Data were then imported into a 
statistical software package (Stata/IC version 15.1, Stata, College Station, Texas, USA) for 
analysis. The study population was described using descriptive statistics. Herd size was 
categorized as large (having 300 or more cows when completing the survey in 2017) or 
moderate (less than 300 cows). 
 
Three health-related outcomes were examined to identify any associated biosecurity factors: 
the producer reported an animal diagnosed with Johne’s disease; the producer answered yes to 
“Have you had an outbreak (treated more than 10%) of animals for shipping fever/pneumonia 
in the last 5 years?”; and the producer answered yes to “Have you had an outbreak (treated 
more than 10%) of animals for calf diarrhea and/or coccidiosis in the last 5 years?”. Each 
outcome was examined separately using logistic regression, and results are reported as odds 
ratios (OR) with 95% confidence intervals (95% CI). All potential risk factors were screened 
using unconditional analysis; factors with P<0.2 were considered for inclusion in the final 
multivariable models. Manual stepwise backward selection was used to develop a main effects 
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model, retaining only variables in which P<0.05. The final model was checked for confounding 
with the variable herd size. 
 
2.4 Results  
2.4.1 Herd demographics 
Eighty-one questionnaires were completed with the last one being returned in May 2018, 
resulting in a response rate of 79%. Herds ranged in size from 34 cows to over 2500, with a 
median of 312 cows (interquartile range (IQR): 161 to 331). Participants reported a median of 
11 breeding bulls (IQR: 7 to 21), 49 replacement heifers (IQR: 29 to 83), and 193 calves (IQR: 
131 to 312), and 22 feeder calves (IQR: 3 to 111). Thirty-one herds were large (≥300 cows) and 
49 were moderate (<300 cows). A total of 95% of respondents reported having commercial 
cows, 22% had purebred cattle, 37% had calves that were being backgrounded (i.e. fed on a 
lower energy ration over the winter prior to entering the feedlot or summer grazing), and 9% 
also had a feedlot. Of the respondents 38 herds were in Alberta, 25 herds were in 
Saskatchewan, and 17 herds were in Manitoba.    
 
2.4.2 Cattle purchases made by producers 
All producers reported buying at least one bull between 2014 and 2017 (Table 2.1). The next 
most common cattle purchased were heifers (54% of herds), cows (42% of herds), foster calves 
(22% of herds), and feeder calves (17% of herds). Over that same time period, the median 
number of bulls purchased was 10, heifers were 32, cows were 15, foster calves was 1, and 




2.4.3 Cattle movements  
Producers were asked where they purchased cattle from and where they sold cattle to in the 
previous 12 months (Table 2.2 and Table 2.3). Three options were given; auction market, 
another farm (cattle purchased or sold directly from or to a different farm), and private sale (a 
sale with a limited number of sellers but could be at any location such as an exhibition grounds 
or auction market (i.e. a bull sale)).  Again, the most common cattle type purchased was bulls 
with 74% of herds purchasing bulls from private sales. Almost half (43%) of herds purchased 
bulls directly from other farms. Heifers were purchased from other farms in 25% of 
participating herds; 19% purchased heifers at a private sale and 14% bought heifers from an 
auction market. Fifteen percent of producers purchased a foster calf from another farm in the 
last 12 months. Ten percent of producers purchased feeder calves from auction markets and 
four percent purchased feeder calves through private sales. Finally, cows were bought from 
another farm in 8% of herds in the previous 12 months; 6% purchased cows through private 
sales and 5% purchased cow through auction markets. 
 
Most cattle were sold through auction markets; 91% of producers sold cows at the auction 
market, 86% sold bulls, and 72% and 70% sold feeder steers and heifers, respectively. The next 
most common location for selling cattle was directly to another farm; 29% of producers sold 
bulls to another farm, while 27% sold heifers to another farm. Sixteen percent of producers 
sold foster calves to another farm. Finally, a smaller number of cattle were sold through private 




2.4.4 Biosecurity practices of cow calf herds in western Canada 
Only 30% of producers kept purchased animals separate from the herd for a period of time, and 
only 30% vaccinated newly purchased animals (Table 2.4). Few producers asked about disease 
history when purchasing new cattle (16%), but most did ask about vaccination history (78%) 
prior to purchase decisions. Custom feeding (feeding cattle for a fee) and custom calving 
(feeding and calving cows for a fee), practices which would potentially bring new animals into 
the herd on a yearly basis, were not common with only 12% and 6% of producers participating 
in these activities, respectively. Community pastures, which mixes herds for summer grazing, 
were used commonly (30%), and 21% of producers took cattle to livestock shows. Only 6% of 
producers had a bull sale on their farm and 31% of producers leased bulls. As well, 19% of 
producers in the study restricted access of visitors to their farm, although 27% of farms had 
hosted visitors from another county in the last 3 years, a potential source of foreign animal 
diseases (Table 2.4). Most producers used the same equipment for handling manure and 
feeding cattle (79%), and only 22% reported that they cleaned equipment after handling 
manure.  
 
2.4.5 Services provided to producers by a veterinarian.  
Almost all producers (97%) indicated they had a working relationship with a veterinarian (Table 
2.5). The three most common veterinary services used were bull breeding soundness 
evaluation (97%), pregnancy diagnosis (95%), and seeking treatment advice (94%). The least 
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common service requested was assistance with setting up written biosecurity protocols at only 
3%.  
 
2.4.6 Health-related outcomes 
Interdigital phlegmon of cattle, more commonly known as footrot, was the most common 
disease in this study with 86% of producers reporting that they had treated at least one case in 
the last 5 years. Almost a third of producers (31%) reported that Johne’s disease had been 
diagnosed in their herd in the past 5 years (Table 2.7). A total of 72% of producers had treated 
at least one case of pneumonia or BRD and 83% of producers had treated at least one case of 
calf diarrhea (Table 2.6). Outbreaks were defined as a situation where a producer treated 10% 
or more of their cattle for a particular disease in a single year; pneumonia (BRD) outbreaks 
were reported in 19% of herds, 22% of cow-calf producers reported having an outbreak of calf 
diarrhea in the past 5 years and coccidiosis outbreaks were reported in 16% of herds. Abortion 
outbreaks where more than 5% of the cow herd aborted in a single year over the last 5 years 
were only reported in 4% of herds.  
 
2.4.7 Factors associated with having Johne’s disease diagnosed in a herd. 
Producers were asked if they had a case of Johne’s disease diagnosed in the herd.  There is a 
possibility that some herds may have had cows with Johne’s disease but may not have been 
aware as it had not been diagnosed or tested for. There were a number of factors 
unconditionally associated (P<0.20) with reporting that a herd had a previous Johne’s disease 
diagnosis (Table 2.8). They included herd size greater than or equal to 300 cows, the purchase 
47  
  
of 10 or more bulls from 2014 to 2017, new animals purchased are not kept separate for a 
period of time, new animals not vaccinated prior to adding them to the herd, producer does 
not ask if John’s disease is present in the source herd, producer has taken cattle to a show in 
the last year, and the producer had a bull sale on the farm in the last year. The exposure 
variables of heifers purchased and cows purchased were not considered for the final model 
even though producers that purchased more than 10 cows or 10 heifers from 2014 to 2017 was 
significant at P<0.20.  The reason for this is heifers purchased and cows purchased were not 
significant when considering those producers that purchased less than 10 cows or heifers. The 
only variable found to be significant (p<0.05) in the final model was the exposure variable of 
new animals are not vaccinated prior to adding them to the herd. However, when herd size was 
added to the model to check for confounding, it did have a greater than 20% effect on the 
exposure variable and was therefore retained in the model. This resulted in the exposure 
variable of new animals not vaccinated prior to adding them to the herd becoming not 
significant. Thus, no exposure variables were found to have a significant impact on whether a 
herd had a diagnosis of Johne’s disease. 
 
2.4.8 Factors associated with bovine respiratory disease outbreaks in a herd 
Approximately one in five producers (19%) reported having an outbreak of bovine respiratory 
disease (BRD) in the previous 5 years. Unconditional associations (P<0.20) with various 
biosecurity management factors are reported individually with the herd outcome of having a 
BRD outbreak in the past 5 years in Table 2.9. A final model was developed that also included 
herd size as a potential confounder. Herd size did not change important effect estimates by > 
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20%, so it was not retained in the final model. In the final model, producers that purchased 
greater than 10 bulls from 2014-2017 (OR: 9.70, 95% CI: 1.68 to 56.0, P = 0.011), bought cows 
in a private sale in the last 12 months (OR: 20.7, 95% CI: 1.25 to 342, P = 0.034), bought cows 
from another farm in the last 12 months (OR: 12.2, 95% CI: 1.11 to 133, P = 0.041), did not 
vaccinate purchased animals (OR: 10.8, 95% CI: 1.22 to 95.0, P = 0.032), and used community 
pasture grazing in 2017 (OR: 6.2, 95% CI: 1.26 to 30.5, P = 0.025), had greater odds of reporting 
a BRD outbreak in the last 5 years than producers that did not report these factors.  
 
2.4.9 Factors associated with an outbreak of calf diarrhea 
A number of herds had either an outbreak of calf diarrhea (22%) or coccidiosis (16%) (Table 
2.6). Upon examining factors unconditionally associated (P<0.20) with a producer reporting a 
calf diarrhea and/or coccidiosis outbreak (Table 2.10), a final model was developed that also 
included herd size as a potential confounder. Herd size did not change important effect 
estimates by > 20%, so it was not retained in the final model. In the final model, producers that 
purchased greater than 10 bulls from 2014-2017 (OR: 3.27, 95% CI: 1.16 to 9.21, P = 0.025), 
used community pasture for grazing in 2017 (OR: 2.86, 95% CI: 0.98 to 8.32, P = 0.054), and 
leased or shared bulls in the last 3 years (OR: 2.86, 95% CI: 0.98 to 8.32, P = 0.054) had greater 
odds of reporting an outbreak of calf diarrhea and/or coccidiosis in the last 5 years.  
 
2.5 Discussion 
Beef cow calf herds in western Canada are typically extensively managed (i.e. predominantly 
spend time grazing on pasture) and this type of management does not easily allow for exclusion 
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biosecurity practices that may be practiced in other livestock systems. There is very little 
information available in the literature regarding the typical biosecurity practices in cow calf 
herds in North America. Most of the available information for western Canada is from a series 
of studies by Waldner et al45,46,123. These studies mostly focused on cow attributes, herd 
management, environmental factors, and other history gathered from western Canadian cow 
calf herds. They did provide some insights into biosecurity practices such as the impact of 
community pasture and vaccination status on the incidence of abortions and non-pregnancy in 
these herds. The current study provided new insights into the general lack of basic biosecurity 
practices in western Canadian cow calf herds.  It also demonstrated the potential negative 
health effects of some of those practices such as adding new adult cattle into the herd and 
communal grazing. 
 
Introducing new animals into a herd presents one of the highest risks for introducing disease43.   
In this study all herds purchased bulls in the time period of 2014-2017 and over half of the 
herds purchased heifers as well, indicating that introduction of new animals into the herd was a 
common practice. Introduction of new cattle into a herd has been studied as a means of  
introduction of bovine tuberculosis47–49, BVDV50–52,120, BHV-153,54, and MAP55–59. Most bulls and 
heifers were purchased from either private sales or from other farms. This is potentially less 
risky from a biosecurity perspective than purchases made from an auction market where there 
is significant mixing of cattle from multiple farms. Chi et al. looked at how to control disease 
transmission in dairy cattle and found that because auctions handle cattle from many farms, 
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there is greater contact with cattle from multiple sources, and therefore more exposure to 
various infectious diseases124. 
 
Biosecurity precautions that would be considered standard practice in other areas of animal 
agriculture were not common in this study. Less than a third of producers kept new additions 
separate and vaccinated new animals. Additionally, many producers mixed their cows with 
other herds in the summer grazing period using community pasture. There was substantial 
mixing of cattle in other ways as well such as custom feeding of calves and taking cattle to 
shows. Finally, only 19% of herds had restricted access for visitors. Interestingly, these results 
are very similar from studies done in England11, Australia20, Finland12, and Belgium15. This 
suggests that exclusion biosecurity for cattle farms the world over is not seen as a priority, and 
probably not perceived as having substantial economic benefit. Partly this can be attributed to 
the fact that beef cattle are more commonly raised extensively (on pasture), not intensively (in 
a confined space). Beef cattle in the North American production system also move from 
breeding farm to backgrounding units to finishing feedlot, thereby encouraging the buying, 
selling, and mixing of cattle along the production chain. Ribble et al. in a large Canadian study 
found that increased mixing or commingling of calves from different ranches increased the risk 
of fatal pneumonia in those calves125. Other studies how shown similar increased risk of BRD 
from mixing calves71,126. 
 
Previous studies have shown that the two most significant calfhood diseases are BRD and calf 
diarrhea118,119. In the current study purchase of cows into the herd had a significant impact on 
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the odds of having a BRD outbreak. Purchasing bulls and leasing or sharing bulls also had a 
significant effect on the odds of an outbreak of calf diarrhea. This seems to demonstrate that 
bringing in adult cattle has an impact on diseases that are primarily a concern in calves, BRD 
and calf diarrhea. We expected to find that cow-calf herds primarily have problems with BRD 
when they purchase feeder cattle, which often have BRD when on feed, and problems with calf 
diarrhea when purchasing foster calves, which often have diarrhea due to failure transfer of 
passive immunity. There has been limited study in this area, with most research from cross-
sectional surveys that are not able to establish causation. Increasing herd size and commingling 
of adults can increase the risk of preweaning BRD and  calf diarrhea68,118,127. The cows and bulls 
themselves could be carrying pathogens as commensal organisms in their respiratory or 
gastrointestinal tracts. Alternatively, transmission could be from more mechanical vectors such 
as cattle trailers that haul the cattle, or the clothes and boots of producers, employees, or 
visitors. There are many potential ways that producers could mitigate this risk.   Careful cow 
and bull selection for purchase based on known disease history and vaccination status of the 
source herd would be the primary means of reducing disease transmission.  Use of artificial 
insemination reduces the need to purchase as many bulls, which could lower risk by reducing 
the number of herds that bulls are sourced from. However, estrus synchronization has been 
shown to increase BRD risk68. Finally, good hygiene practices such as cleaning trailers and 
clothing has been shown to reduce disease transmission in the case of other diseases62–64; 
however, its uncertain of the impact these practices would have on reducing BRD and calf 




Using community pasture was the other factor that increased the risk of both BRD and calf 
diarrhea. This is the practice of mixing multiple cow-calf herds together in the same pasture 
during the summer grazing period in western Canada. This practice was common in the current 
study with 30% of producers using communal grazing in the year of study.  This compares to 20 
-22% in other Canadian studies128,129. Cows sent to community pasture are more likely to mix 
with herds of differing biosecurity status. Cows grazed on community pastures and not 
vaccinated for BVDV or BHV-1 were more likely to abort in one study46. A similar study by the 
same author also found that cows bred on community pasture and not vaccinated for BHV-1 
and BVDV were less likely to be pregnant45.  A Brazilian study found that communal grazing 
increased the risk of BHV-1 infection54, and a Swiss study found that the risk of BVDV 
introduction was higher in herds that grazed communally120.  Based on this research the 
increased risk of disease introduction from communal grazing seems to be prevalent in other 
countries as well.   
 
It is interesting to note that BRD and calf diarrhea in pre-weaned calves are often found 
together68,130. They potentially share common risk factors such as housing density and poor 
hygiene69,119,130. In the current study 9 of the 15 herds that reported having a BRD outbreak, 
also reported having an outbreak of calf diarrhea. Other aspects of pasture grazing that have 
been shown to increase the risk of BRD in pre-weaned calves are increasing the number of 
cows, more intensive grazing practices and estrus synchronization programs131. This suggests 
that factors such as increased mixing and density of cows increases the risk of BRD on pasture. 
Based on that information and the increased risk of BRD and calf diarrhea outbreaks shown in 
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this study, finding alternatives to community pasture should be a consideration for producers. 
Purchase of individually owned pastures is probably the best solution. Where this isn’t feasible 
due to cost or availability, options such as splitting community pastures into smaller sections to 
reduce the mixing of herds and developing similar biosecurity protocols to the other producers, 
should be considered. 
 
The last factor associated with increased risk of BRD, although not an increased risk of calf 
diarrhea, was not vaccinating purchased animals upon arrival. The efficacy of vaccinating calves 
to prevent BRD is well established70,71,127,132–134. The questionnaire did not distinguish between 
the vaccination of adult new arrivals or calves.  The findings of this study that purchase of adult 
animals increases BRD risk in calves would support vaccination of adult new arrivals.  Recent 
work on vaccination practices from herds in the WCCSN showed that 91% of cows and 96% of 
replacement heifers are vaccinated at least once for BVDV and BHV-1113, so this practice is 
commonplace already.  This research would suggest that vaccinating purchased cattle for the 
common viral and bacterial BRD pathogens is a sound biosecurity practice. 
 
There is potential in this study, like all survey-based research, for recall bias.  It may have been 
difficult for a producer to recall all the purchases made and selling of animals in the last number 
of years.  However, this is helped somewhat by the fact that most of these activities do not vary 
substantially on each farm from year to year.  In the same way, it is likely that a producer does 
not change their biosecurity practices appreciably from year to year.  So, for example, the 
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effect of practices such as community pasture grazing in the previous year can be extrapolated 
over time.   
Another criticism is that the study does not represent a random sample.  The WCCSN has herds 
recruited through local veterinary practices in western Canada.  This could result in herds that 
are more likely to be involved with their local veterinarian.  In turn, this could influence their 
knowledge and application of biosecurity practices.    
 
2.6 Conclusion 
It is interesting that the introduction of adult animals into a herd has such a significant 
association with diseases that are primarily a concern in calves prior to and just after weaning, 
namely BRD and calf diarrhea. The mechanism of how these pathogens spread from the newly 
introduced cattle into calves is an area that requires further study. Community pasture grazing 
was the other factor that was associated with both BRD and calf diarrhea outbreaks. Multiple 
studies from other areas of the world show similar results44–46,54,120. It would seem that 
purchase of new animals and community pasture grazing are two aspects of cow-calf 
production that can compromise biosecurity and affect animal health and warrant caution on 
the part of the producer. This study demonstrates there is minimal consideration of biosecurity 
on cow-calf operations in western Canada. Efforts should be made to reduce the introduction 
of new cattle into cow calf herds and to improve isolation and vaccination protocols for these 
cattle on cow-calf operations.  As well communal grazing should be used as minimally as is 





Table 2.1 Cattle purchases made by producers 2014-2017 reported by 80 cow-calf producers 
surveyed in western Canada (n=80). 
 

















































































































































Table 2.2 Locations cattle purchased from in the 12 months previous to the survey reported by 
80 cow-calf producers surveyed in western Canada (n=80). 
 
 Auction Market Another Farm Private Sale 
 Percentage of 
Producers who 
purchased 









































0% 0 43% 2 (1-20) 74% 3 (1-11) 
Cows 
 
5% 20 (11-43) 8% 29 (1-94) 6% 2 (1-46) 
Heifers 
 
14% 20 (3-300) 25% 8 (1-73) 19% 3 (1-69) 
Foster Calves 
 
0% 0 15%  1 (1-4)) 0% 0 
Feeder 
Calves 
10% 121 (1-1800) 4% 200 (1-3066) 0% 0 
 
Table 2.3 Locations cattle sold to in the 12 months previous to the survey reported by 80 cow-
calf producers surveyed in western Canada (n=80). 
 
 Auction Market Another Farm Private Sale 
 Percentage of 
Producers who 
sold cattle 



































86% 3 (1-10) 29% 6 (1-36) 12% 42 (1-82) 
Cows 
 
91% 24 (6-89) 14% 21 (1-1200) 4% 40 (33-50) 
Heifers 
 
35% 11 (2-67) 27% 25 (2-70) 12% 7 (1-57) 
Foster Calves 
 




70% 50 (5-175) 12% 64 (4-1500) 2.5% 53 (6-100) 





Table 2.4 Responses of producers in survey to general biosecurity questions (n=80). 
Survey Questions Yes No Under Certain 
Circumstances 
    
New animals purchased kept separate for a period of time.  30% 46% 24% 
New animals are vaccinated prior to adding them to the 
herd. 
30% 68%  
Producer asks about disease history prior to purchasing 
new animals. 
16% 64% 17% 
Producer asks about vaccination history prior to purchasing 
new animals. 
78% 20% 1% 
Producer has custom fed calves on their farm in the last 3 
years. 
12% 85%  
Producer has custom calved cows on their farm in the last 3 
years. 
6% 93%  
Producer uses community pasture for summer grazing 30% 69%  
Producer has taken cattle to a show in the last year 21% 78%  
Producer had a bull sale on their farm in the last year 6% 93%  
Producer has leased bulls for use on their farm in the last 3 
years 
31% 67%  
Producer restricts access of people from other farms to 
their cattle. 
19% 63% 16% 
People from other countries had visited the producers farm 
in the last 3 years. 
27% 70%  
Producer uses the same equipment for manure handling 
and feeding cattle. 
79% 19%  
Producer cleans and disinfects loader after handling 
manure. 




Table 2.5 Services provided to producers by their veterinarian (n=79) (one producer did not 






Relationship that producers have with their veterinarian and services that are provided. 
(n=79) 
Yes 
Producer has a working relationship with a veterinarian.  97% 
Producer uses their veterinarian for the following services:  
Pregnancy Diagnosis 95% 
Bull Testing 97% 
Body Condition Scoring 24% 
Routine Post Mortems of Dead Cattle 49% 
Trichomoniasis Testing of Bulls 21% 
Treatment of sick animals  72% 
Assisting with calving difficulty: ie. C-section 89% 
Advice regarding vaccines 92% 
Treatment advice 94% 
Biosecurity advice 28% 
Disease prevention advice 67% 
Written vaccine protocols 32% 
Written treatment protocols 27% 
Written biosecurity protocols 3% 
Assistance with quality assurance programs 9% 
Marketing advice 5% 
Staff employee or family member training 14% 
Feed analysis or ration formulation 14% 
Advice regarding nutrition 29% 
Testing for other infectious diseases (e.g. Johne’s, BVD, etc) 42% 
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Table 2.6 Health related outcomes when producers were asked questions about diseases that 
they observe in their herds (n=80). 
 




Table 2.7 Health related outcomes when producers were asked questions about diseases that 
they observe in their herds (n=80). 
 
Health Related Outcome (n=80) Yes No Missing 
Producer had more than 5% of their herd abort in a single calving season. 4% 94% 3% 







Health Related Outcome (n=80) Percentage of herds that 
have treated an animal for 
the disease 
Percentage of herds that 
have had an outbreaka of 
the disease 
Shipping Fever / Pneumonia 72% 19% 
Calf Diarrhea / Scours 83% 22% 
Coccidiosis 58% 16% 
Infectious Bovine Rhinotracheitis 6% 0% 
Bovine Viral Diarrhea 6% 0% 
Pinkeye 69% 16% 
Footrot 86% 12% 
Trichomoniasis 1% 0% 








Table 2.8 The unconditional associations of exposure variables to outcome (Answered Yes to 
“Have you had Johne’s disease diagnosed in your herd?”) 
 






  Lower Upper  
     
Cattle have contact with Dairy Cattle: no contact with Dairy 
cattle 
2.26 0.30 17.1 0.43 
Herd Size ≥300 Cows: <300 cows 3.02 1.13 8.07 0.027 
1-10 Bulls Purchased from 2014-2017 1    
10 or more Bulls Purchased from 2014-2017 2.29 0.87 6.04 0.095 
1-10 Cows Purchased from 2014-2017 1.70 0.35 8.22 0.51 
10 + Cows Purchased from 2014-2017 2.02 0.71 5.75 0.19b 
1-10 Heifers Purchased from 2014-2017 1.50 0.44 5.17 0.52 
10 + Heifers Purchased from 2014-2017 2.14 0.71 6.49 0.18c 
1 + Foster Calves Purchased from 2014-2017 0.42 0.11 1.63 0.21 
1 + Feeder Calves Purchased from 2014-2017 2.08 0.62 6.99 0.24 
     
Purchased Bulls from Another Farm in the previous 12 
months 
0.68 0.26 1.81 0.44 
Purchased Bulls from a Private Sale in the previous 12 
months 
0.74 0.25 2.20 0.59 
Purchased Cows from Another Farm in the previous 12 
months 
2.50 0.46 13.4 0.29 
Purchased Cows from a Private Sale in the previous 12 
months 
0.53 0.06 5.04 0.58 
Purchased Heifers from Auction Market in the previous 12 
months 
0.92 0.52 7.02 0.33 
Purchased Heifers from Another Farm in the previous 12 
months 
0.97 0.32 2.95 0.96 
Purchased Heifers from a Private Sale in the previous 12 
months 
2.52 0.32 2.95 0.96 
Purchased Foster Calves from Another Farm in the previous 12 
months 
0.80 0.19 3.34 0.76 
Purchased Feeder Calves from Auction Market in the previous 12 
months 
1.34 0.29 6.15 0.70 
Purchased Feeder Calves from Another Farm in the previous 12 
months 
1.11 0.10 12.9 0.93 
     
New animals purchased are not kept separate for a period of time.  0.52 0.20 1.39 0.19 
New animals are not vaccinated prior to adding them to the herd. 0.29 0.10 0.80 0.017 
Producer does not ask about disease history prior to purchasing new 
animals.  
0.65 0.24 1.75 0.39 
Producer has Feeder cattle that have direct contact with Cows. 0.50 0.03 7.45 0.61 
Producer does not ask if Johne’s disease is present in source herd. 0.31 0.06 1.50 0.15 
Producer does not ask about vaccination history prior to purchasing 
new animals. 
0.45 0.12 1.76 0.25 
Producer has custom fed calves on their farm in the last 3 years. 1.49 0.38 5.85 0.57 
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Producer has custom calved cows on their farm in the last 3 years. 1.48 0.23 9.46 0.68 
Producer uses community pasture for summer grazing. 1.90 0.70 5.21 0.21 
Producer has taken cattle to a show in the last year. 2.35 0.78 7.10 0.13 
Producer had a bull sale on the farm in the last year 3.55 0.55 22.7 0.18 
Producer has leased bulls for use on their farm in the last 3 years. 1.30 0.48 3.56 0.61 
Producer restricts access of people from other farms to their cattle.  1.33 0.50 3.55 0.57 
People from other countries had visited the producers farm 
in the last 3 years. 
0.75 0.25 2.22 0.60 
Producer uses the same equipment for manure handling and 
feeding cattle. 
0.91 0.27 3.01 0.88 
Producer cleans and disinfects loader after handling manure. 1.41 0.52 3.85 0.50 
a P-value , 0.20 retained for consideration in the final multivariable models.  
bNot considered for final model as overall p-value for cows purchased was >0.20. 




Table 2.9 The unconditional associations of exposure variables to outcome (answered YES to 
the question, “have you had an outbreak (treated more than 10%) of animals for shipping 
fever/pneumonia in the last 5 years?”) (n = 80 herds) 
 






  Lower Upper  
     
Herd Size ≥300 Cows: <300 cows 1.50 0.48 4.64 0.49 
1-10 Bulls Purchased from 2014-2017 1.00    
10 or more Bulls Purchased from 2014-2017 4.02 1.15 14.01 0.03 
1-10 Cows Purchased from 2014-2017 1.36 0.24 7.78 0.73 
10 + Cows Purchased from 2014-2017 1.25 0.36 4.34 0.73 
1-10 Heifers Purchased from 2014-2017 1.25 0.34 4.53 0.73 
10 + Heifers Purchased from 2014-2017 0.32 0.06 1.65 0.17 
1 + Foster Calves Purchased from 2014-2017 0.89 0.22 3.61 0.87 
1 + Feeder Calves Purchased from 2014-2017 0.74 0.15 3.76 0.72 
     
Purchased Bulls from Another Farm in the previous 12 months 2.34 0.74 7.38 0.15 
Purchased Bulls from a Private Sale in the previous 12 months 0.96 0.27 3.43 0.95 
Purchased Cows from Another Farm in the previous 12 months 4.92 0.88 27.36 0.07 
Purchased Cows from a Private Sale in the previous 12 months 7.63 1.15 50.64 0.04 
Purchased Heifers from Auction Market in the previous 12 
months 
0.42 0.05 3.54 0.42 
Purchased Heifers from Another Farm in the previous 12 
months 
1.09 0.30 3.91 0.89 
Purchased Heifers from a Private Sale in the previous 12 
months 
0.59 0.12 2.96 0.52 
Purchased Foster Calves from Another Farm in the previous 12 
months 
0.82 0.16 4.18 0.81 
Purchased Feeder Calves from Auction Market in the previous 
12 months 
1.58 0.28 8.82 0.60 
     
     
New animals purchased are not kept separate for a period of time.  1.02 0.33 3.15 0.97 
New animals are not vaccinated prior to adding them to the herd. 3.07 0.63 14.94 0.17 
Producer does not ask about disease history prior to purchasing new 
animals.  
1.05 0.32 3.45 0.94 
Producer has Feeder cattle that have direct contact with Cows. 0.50 0.03 8.71 0.63 
Producer does not ask if Johne’s disease is present in source herd. 0.66 0.12 3.65 0.64 
Producer does not ask about vaccination history prior to purchasing 
new animals. 
1.58 0.43 5.81 0.50 
Producer has custom fed calves on their farm in the last 3 years. 2.04 0.46 9.02 0.35 
Producer has custom calved cows on their farm in the last 3 years. 1.09 0.11 10.51 0.94 
Producer uses community pasture for summer grazing. 3.50 1.10 11.17 0.03 
Producer has taken cattle to a show in the last year. 3.27 0.97 11.08 0.06 
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Producer has leased bulls for use on their farm in the last 3 years. 2.24 0.71 7.07 0.17 
Producer restricts access of people from other farms to their cattle.  1.79 0.57 5.60 0.32 
People from other countries had visited the producers farm in 
the last 3 years. 
0.93 0.26 3.30 0.91 
Producer uses the same equipment for manure handling and 
feeding cattle. 
1.66 0.33 8.28 0.54 
Producer cleans and disinfects loader after handling manure. 1.58 0.50 4.98 0.43 




Table 2.10 The unconditional associations of exposure variables to outcome (answered YES to 
the question, “have you had an outbreak (treated more than 10%) of animals for Calf Diarrhea 
and/or Coccidiosis in the last 5 years?”) 
 





  Lower Upper  
     
Cattle have contact with Dairy Cattle: no contact with Dairy 
cattle 
2.04 0.27 15.34 0.49 
Herd Size ≥300 Cows: <300 cows 2.28 0.88 5.90 0.09 
1-10 Bulls Purchased from 2014-2017 1.00    
10 or more Bulls Purchased from 2014-2017 2.72 1.04 7.11 0.04 
1-10 Cows Purchased from 2014-2017 1.27 0.28 5.85 0.76 
10 + Cows Purchased from 2014-2017 2.15 0.77 6.00 0.15 
1-10 Heifers Purchased from 2014-2017 0.92 0.29 2.89 0.88 
10 + Heifers Purchased from 2014-2017 0.52 0.17 1.64 0.27 
1 + Foster Calves Purchased from 2014-2017 1.07 0.35 3.28 0.91 
1 + Feeder Calves Purchased from 2014-2017 3.96 1.15 13.65 0.03 
     
Purchased Bulls from Another Farm in the previous 12 
months 
2.17 0.84 5.59 0.11 
Purchased Bulls from a Private Sale in the previous 12 
months 
0.93 0.32 2.71 0.89 
Purchased Cows from Auction Market in the previous 12 
months 
0.60 0.06 6.09 0.67 
Purchased Cows from Another Farm in the previous 12 
months 
1.96 0.37 10.45 0.43 
Purchased Cows from a Private Sale in the previous 12 
months 
1.28 0.20 8.17 0.79 
Purchased Heifers from Auction Market in the previous 12 
months 
0.67 0.16 2.77 0.58 
Purchased Heifers from Another Farm in the previous 12 
months 
1.05 0.36 3.05 0.93 
Purchased Heifers from a Private Sale in the previous 12 
months 
1.88 0.60 5.91 0.28 
Purchased Foster Calves from Another Farm in the previous 12 
months 
0.94 0.25 3.44 0.92 
Purchased Feeder Calves from Auction Market in the previous 12 
months 
3.56 0.78 16.25 0.10 
Purchased Feeder Calves from Another Farm in the previous 12 
months 
0.94 0.08 10.89 0.96 
     
New animals purchased are not kept separate for a period of time.  1.41 0.55 3.56 0.47 
New animals are not vaccinated prior to adding them to the herd. 1.06 0.38 2.91 0.92 
Producer does not ask about disease history prior to purchasing new 
animals.  
1.06 0.40 2.83 0.91 
Producer has Feeder cattle that have direct contact with Cows. 3.00 0.20 45.24 0.43 
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Producer does not ask if Johne’s disease is present in source herd. 0.47 0.11 2.05 0.31 
Producer does not ask about vaccination history prior to purchasing 
new animals. 
1.29 0.41 4.04 0.66 
Producer has custom fed calves on their farm in the last 3 years. 3.43 0.07 1.14 0.08 
Producer has custom calved cows on their farm in the last 3 years. 3.19 0.05 2.00 0.22 
Producer uses community pasture for summer grazing. 2.73 0.14 0.99 0.05 
Producer has taken cattle to a show in the last year. 2.06 0.16 1.45 0.20 
Producer had a bull sale on the farm in the last year 0.47 0.23 19.98 0.51 
Producer has leased bulls for use on their farm in the last 3 years. 2.40 0.16 1.12 0.08 
Producer restricts access of people from other farms to their cattle.  0.67 0.55 4.02 0.44 
People from other countries had visited the producers farm in the 
last 3 years. 
1.14 0.31 2.45 0.80 
Producer uses the same equipment for manure handling and 
feeding cattle. 
1.05 0.29 3.14 0.94 
Producer cleans and disinfects loader after handling manure. 0.68 0.53 4.04 0.46 





Chapter 3. Antimicrobial Resistance in Bovine Respiratory Disease: Auction Market and Ranch 
Raised Calves 
Calves from the auction market (n=299) and calves from a single ranch source (n=300) were 
tested for prevalence and antimicrobial sensitivity of three major BRD bacterial pathogens 
(Mannheimia haemolytica (MH), Pasteurella multocida (PM) and Histophilus somni (HS)) at 
arrival and again later in the feeding period. In the auction market calves the prevalence of MH 
decreased and the prevalence of HS increased over the feed period.  In the single source ranch 
calves the prevalence of all three BRD pathogens decreased. In most cases antimicrobial 
resistance increased over the period except in the case of MH isolates in the single source 
ranch calves where antimicrobial resistance decreased.   
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3.1 Abstract  
Bovine respiratory disease (BRD) is the most significant disease in the feedlot industry. This 
study aims to compare the changes in prevalence and antimicrobial sensitivity of three major 
BRD bacterial pathogens at arrival and again later in the feeding period in feedlot calves derived 
from the auction market and from a single ranch source. The animals used were 299 auction 
market-derived (AUCT) and 300 ranch-sourced (RANCH) beef calves for a commercial feedlot. 
Calves were sampled with a deep nasal pharyngeal swab (DNS) at the time of entry to the 
feedlot and again at 64-168 days after arrival. The swabs were cultured within 24 hours of 
sampling followed by antimicrobial sensitivity testing of isolates of Mannheimia haemolytica 
(MH), Pasteurella multocida (PM) and Histophilus somni (HS). In the AUCT calves, the 
prevalence of calves with MH decreased from 37.8% to 20.3% (P <0.001) and the prevalence of 
calves with HS increased from 17.1% to 30.4% (P = 0.001) over the sampling period. There was a 
significant increase in calves with isolates that were not sensitive to tulathromycin from the 
first to second test of all bacterial pathogens. Also in AUCT calves there was a significant 
increase in calves with PM isolates not sensitive to florfenicol and oxytetracycline, and calves 
with HS isolates not sensitive to oxytetracycline and tilmicosin. In the RANCH calves, prevalence 
of calves with MH isolates dropped from 29.4% to 20.4% (P =0.01), from 60.0% to 43.4% for PM 
(P <0.001), and from 39.8% to 6.1% for HS (P <0.001). In these calves there was a significant 
increase in PM samples not sensitive to oxytetracycline, tilmicosin, tulathromycin and 
florfenicol. There was a significant decrease in MH isolates that were not sensitive to 
oxytetracycline, tilmicosin and tulathromycin. Almost all isolates were sensitive to ceftiofur or 
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enrofloxacin. Antimicrobial resistance of BRD pathogens and prevalence of bacterial pathogens 
can vary between auction market-derived and single source calves over the feeding period. 
 
3.2 Introduction  
Bovine Respiratory Disease (BRD) is the leading cause of sickness and death in feedlot beef 
cattle in North America135. A lack of effective antimicrobials has the potential to further 
increase that impact. Despite thousands of studies over the last 30 years75, BRD still remains a 
major problem in cattle production. 
There is a clear trend of increasing resistance to antimicrobials in the major BRD pathogens of 
Mannheimia haemolytica, Pasteurella multocida and Histophilus somni90,93,97,135,136. Resistance 
to tetracyclines is the most common, particularly in M. haemolytica and P. multocida, with 
multiple studies since 1988 showing less than 50% of isolates susceptible to 
tetracycline89,90,93,97. The next most common is resistance to the macrolide class of 
antimicrobials, including drugs such as tilmicosin, gamithromycin, tulathromycin, and 
tildipirosin. Susceptibility to drugs in this class has been steadily decreasing since 1990 when 
tilmicosin, the first macrolide available in Canada, was introduced89,90. For the most part, 
susceptibility of the major BRD pathogens to florfenicol, the fluoroquinolones, and ceftiofur 
remains high, most often between 90 and 100%89,90,97,98. Two recent and somewhat alarming 
studies have shown nearly 100% resistance to multiple antimicrobials in Mannheimia 




As antimicrobials become less effective there will be a need to reduce morbidity and mortality 
in feedlot calves through means other than the use of antimicrobials. One way to potentially 
reduce the risk of BRD in feedlot calves is by acquiring calves for the feedlot directly from a 
known single source instead of multiple unknown sources. Step et al.71 showed that single 
source calves were less likely to be treated for BRD than auction market-derived calves, and 
calves that were weaned 45 days prior to feedlot entry also were less likely to be treated. In a 
large Canadian study Ribble et al. found that mixing and commingling of calves from multiple 
ranches at the auction market increased the risk of fatal pneumonia in the feedlot125.  There is 
also the process known as preconditioning, where calves are vaccinated, weaned, dehorned, 
dewormed, castrated, and trained to eat from a bunk prior to entry into the feedlot.  In many 
cases with this practice there are single or fewer sources, and less mixing. Preconditioning has 
been shown to reduce morbidity and mortality in the feedlot70,73. Making strategic 
management decisions on the source of calves being purchased and how much commingling 
has occurred in those calves seems to have a significant impact on the development of BRD. 
 
The objective of this study was to describe the prevalence and antimicrobial sensitivity of 3 
major bovine respiratory pathogens (Mannheimia haemolytica, Pasteurella multocida and 
Histophilus somni) in calves derived from the auction market and those from a single source 
ranch. A secondary objective was to compare the results in these calves at arrival and again 




3.3 Materials and Methods 
3.3.1 Ethics Statement 
The research protocol was reviewed and approved by the University of Saskatchewan Animal 
Care Committee, AUP #20140003. 
3.3.2 Animals  
Recently weaned steers and heifers of various mixed beef breeds were used for this study. The 
study was conducted at a commercial feedlot with an 8000 head one-time capacity. The feedlot 
typically buys auction market-derived, recently weaned calves each fall. They also feed calves 
from their own commercial cow-calf herd. A sample of 299 auction market-derived calves 
(AUCT) were randomly selected on arrival at the feedlot for study. As well, 300 calves from the 
above-mentioned commercial cow-calf herd (RANCH), were randomly selected on arrival at the 
feedlot. The calves all entered the feedlot in November and December 2017.  
 
3.3.3 Study design 
Each calf had a deep nasopharyngeal swab (DNS) performed at the time of processing on entry 
to the feedlot. The double guarded swab (Reproduction Provisions LLC, Walworth, WI) was 
advanced up the ventral meatus of the nose to the level of the medial canthus of the eye, a 
cotton tipped swab was advanced into the deep nasopharynx, and the swab was swirled on the 
mucosa approximately 6-10 times, as described elsewhere137. Depending on the size of the 
group being processed samples were collected from every 2nd or 3rd calf as they came through 
the chute – for example if the group being sampled was approximately 300 calves, then a 




These samples were placed into Ames media (Copan Diagnostics Inc, Marrieta, CA) and 
transported in cooled containers to Prairie Diagnostics Laboratory in Saskatoon, Saskatchewan 
overnight. Isolates were initiated the following morning on 5% Columbia sheep blood and 
Chocolate agar plates and incubated at 35°C for 18 hours in an environment containing 5% CO2, 
for isolation of Histophilus somni, Mannheimia haemolytica, and Pasteurella multocida. 
Bacterial colonies were examined for cultural characteristics such as production of yellow 
pigment (H. somni), β-hemolysis (M. haemolytica), and mucoid appearance (P. multocida), at 18 
and 48 hours of incubation. The microorganisms of interest were identified using the Matrix 
Assisted Laser Desorption and Ionization Time of Flight (MALDI-TOF) Mass Spectrometry 
System. Briefly, individual bacterial colonies were transferred onto the stainless steel MALDI-
TOF target in duplicate. Each target well was overlaid with 1 μl of α-cyano-4- hydroxycinnamic 
acid (HCCA) matrix, and the mass spectra were acquired using MALDI-TOF MF, Microflex LT 
system in a linear positive mode. Instrument calibration was performed using standard 
reference Escherichia coli. For bacterial identification, MALDI Biotyper 3.1.66 was used. The 
cut-off scores used for bacterial identification were ≥2.0. Only isolates that positively identified 
with scores equal or greater than 2.0 were included in this study. Positive isolates of 
Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni were frozen at -80 0C 
for later sensitivity testing, as described elsewhere137. 
 
Sensitivity testing was by broth microdilution (Sensititre, Thermofisher Scientific, Nepean, ON, 
Canada) using a commercially available panel (BOPO6F custom bovine plates, Thermofisher 
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Scientific, Nepean, ON, Canada). These plates look for sensitivity to the following 
antimicrobials: ceftiofur, tiamulin, chlortetracycline, gentamicin, florfenicol, oxytetracycline, 
penicillin, ampicillin, danofloxacin, enrofloxacin, sulphadimethoxine, neomycin, trimethoprim/ 
sulfamethoxazole, spectinomycin, tylosin tartrate, tulathromycin, tilmicosin, and clindamycin. 
Briefly, the bacteria are inoculated into a series of wells on the plate containing the specific 
antimicrobial in increasing concentrations. The Sensititre plates used have a 96 well microtiter 
plate format containing doubling dilutions. Each plate also contains positive and negative 
controls138,139. The MICs are determined using an automated viewing device by observing the 
lowest concentration of antimicrobial agent that completely inhibits growth of the 
organism138,139. 
 
Isolates were categorized as resistant to an antimicrobial according to minimum inhibitory 
concentrations (MIC) defined by the Clinical and Laboratory Standards Institute for ceftiofur (≥ 
8 μg/mL), enrofloxacin (≥ 2 μg/mL), florfenicol (≥ 8 μg/mL), penicillin (≥ 1 μg/mL), 
oxytetracycline (≥ 8 μg/mL), tilmicosin (≥ 32 μg/mL, for M. haemolytica), and tulathromycin (≥ 
64 μg/mL)140. The CLSI breakpoints were not available for ampicillin, clindamycin, 
chlortetracycline, danofloxacin (for H. somni), gentamycin, spectinomycin, tiamulin, tilmicosin 
(for P. multocida and H. somni), trimethoprim/sulfamethoxazole, tylosin, and neomycin.  
 
Each calf was treated on arrival with a subcutaneous injection of a long-acting macrolide to 
control BRD (tulathromycin, Draxxin, 2.5 mg/kg, Zoetis, Kirkland, QC, Canada), then weighed 
and vaccinated against infectious bovine herpes virus-1 (BHV-1), bovine viral diarrhea virus 
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(BVDV; types I and II), bovine parainfluenza-3 (Pi3), bovine respiratory syncytial virus (BRSV), 
Mannheimia haemolytica, Histophilus somni and clostridial pathogens (Bovishield Gold One 
Shot, Zoetis, Kirkland, QC, Canada) and Vision 8 Somnus, (Merck Animal Health, Kirkland, QC). 
The calves were also administered an anthelminthic (Bimectin, Bimeda-MTC, Cambridge, ON, 
Canada). In addition, auction market-derived heifers received 1mg cloprostenol in the muscle 
(Estrumate, Merck Animal Health, Kirkland, QC) to induce abortion.   
 
Steers and heifers were housed separately by sex and fed in large outdoor dirt-floor pens in 
groups of 100 to 250 cattle. The study cattle remained in the larger groups with which they 
entered the feedlot; that is, AUCT cattle and RANCH cattle did not mix. All cattle received two 
doses of chlortetracycline (aureomycin, Zoetis, Kirkland, QC, Canada) within the first 28 days on 
feed (DOF) to prevent histophilosis as per standard feedlot procedure. A dose consisted of 
feeding 6 g of chlortetracycline per animal per day for 7 days in the total mixed ration and 
doses generally occurred during the second and fourth weeks on feed for each pen. Calves 
were identified by radio frequency ear tag.  
 
A second DNS was collected from enrolled calves. These samples were also submitted for 
culture and sensitivity testing as described above. The AUCT calves received another 
vaccination against BHV-1 and Pi3 (Bovi-shield IBR-Pi3, Zoetis, Kirkland, QC, Canada) at the time 
of the second swab.  This was an average of 76 days after the first swab. A total of 217 AUCT 
calves were resampled. The RANCH calves did not receive a vaccination at the time of the 
second swab and a change in feedlot protocol delayed resampling until an average of 153 days 
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after the first swab.  A total of 279 RANCH calves were resampled. Calves that were not 
resampled were lost to follow-up due to death or being sold from the feedlot. 
 
Cattle were observed daily by experienced pen checkers for detection of clinical illness. Cattle 
with one or more visual signs of BRD (e.g. depression, nasal or ocular discharge, cough, 
increased respiratory rate or dyspnea) were removed from the pens by pen checkers and, if not 
previously treated for BRD or another disease, were treated for BRD. Calves that required a first 
treatment for a case of clinical BRD were administered enrofloxacin (Baytril 100, Bayer Animal 
Heath, Mississauga, ON) at 10 mg/kg. Calves that required a second treatment for BRD were 
given florfenicol (Nuflor, Merck Animal Health, Kirkland, QC) at 40 mg/kg. No calves in this 
study were treated more than 2 times.  
 
3.3.4 Statistical analysis 
Data was collected for each calf on the prevalence of positive isolates for the BRD pathogens 
(M. haemolytica, P. multocida and H. somni). Based on the available CLSI cut-points for each 
antimicrobial, BRD pathogens were classified as sensitive, resistant and intermediate. This data 
was entered into a commercial spreadsheet program (Excel 2017; Microsoft Corp., Redmond, 
Washington, USA) then imported into a statistical software package (Stata/IC version 15.1, 
Stata, College Station, Texas, USA) for analysis. Isolates that were classified as intermediate or 
resistant were grouped together and termed not sensitive, as compared to sensitive isolates. 
The prevalence of BRD pathogens and sensitivity data was summarized in two ways; prevalence 
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of positive BRD isolates and isolates that were not sensitive to antimicrobials, as well as looking 
at calves as matched pairs from the first to the second test.  
The prevalence of positive isolates and the prevalence of isolates not sensitive to each 
antimicrobial for the three BRD pathogens were compared from the first test to the second test 
using McNemar’s test for paired data within calf source groups. The same prevalence data for 
the three BRD pathogens was compared between AUCT calves and RANCH calves for the first 
test, using Fisher’s exact test.  
 
Treatment risk for BRD and crude mortality risk over the feeding period were compared 
between AUCT calves and RANCH calves using Fisher’s exact test. Logistic regression models 
were used to determine whether isolation of BRD pathogens or antimicrobial resistance of BRD 
pathogens might be associated with treatment for BRD or crude mortality. Potential risk factors 
were screened with unconditional analysis; factors with P<0.20 were considered for inclusion in 
the final multivariable models. Finally, the association was examined between antimicrobial 
treatment for BRD and antimicrobial resistance (AMR) in M. haemolytica, P. multocida and H. 
somni on the 2nd test. All the final multivariable models were constructed in the same way. The 
final models included source (AUCT and RANCH) and the interaction of treatment and source. If 
the interaction was significant then the pairwise comparisons for treated and untreated AUCT 
and RANCH calves were reported. If the interaction was not significant, it was removed from 





3.4.1 Prevalence of positive isolates for M. haemolytica, P. multocida, and H. somni 
At the first test there was a significantly higher culture prevalence for M. haemolytica in AUCT 
calves at 39.5% compared to 29.7% for RANCH calves (P = 0.013; Table 3.1). However, the 
RANCH calves had higher culture prevalence for P. multocida and H. somni at 60.0% (P <0.001) 
and 38.7% (P <0.001), respectively compared to 28.1% and 14.8% for the AUCT calves. In the 
AUCT calves, prevalence of positive isolates of M. haemolytica dropped significantly from 37.8% 
at the first test to 20.3% at the second test (P <0.001; Table 3.2). There was no significant 
change in P. multocida culture prevalence from the first to second tests in AUCT calves, but 
positive H. somni isolates increased significantly from 17.1% to 30.4% (P = 0.001). From the first 
to the second test positive culture prevalence dropped significantly for all three pathogens in 
the RANCH calves (Table 3.2). For M. haemolytica prevalence dropped from 29.4% to 20.4% (P 
=0.01), from 60.0% to 43.4% for P. multocida (P <0.001), and from 39.8% to 6.1% for H. somni 
(P <0.001). 
 
3.4.2 Antimicrobial sensitivity of M. haemolytica, P. multocida, and H. somni isolates to the 
most commonly used antimicrobials 
In the AUCT calves at the first test, 26.7% of the M. haemolytica isolates were not sensitive to 
oxytetracycline and 27.6% were not sensitive to tilmicosin (Table 3.3). The RANCH calves had 
similar results on arrival with 20.3% of M. haemolytica isolates not sensitive to oxytetracycline 
and 19.0% not sensitive to each tilmicosin and tulathromycin. In AUCT calves that were tested 
twice, there was a significant increase in calves not sensitive to tulathromycin on the second 
test; from 1.4% to 7.4% (P = 0.04). In the RANCH calves tested twice, calves with non-sensitive 
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isolates of M. haemolytica decreased significantly in the second test from 5.7% to 0.4% for 
oxytetracycline (P < 0.001), and from 5.4% to 0% for both tilmicosin and tulathromycin (P < 
0.001).  
 
For the P. multocida isolates in AUCT calves prevalence of non-sensitive bacteria was relatively 
low in the first test (Table 3.4). All isolates were sensitive to chlortetracycline, florfenicol, and 
tulathromycin, with only a few isolates not sensitive to oxytetracycline and tilmicosin. The 
pattern was similar in the RANCH calves for P. multocida, with only a few non sensitive isolates 
for each antimicrobial (Table 3.4). In the AUCT calves tested twice, the prevalence of calves 
with P. multocida isolates not sensitive to florfenicol increased significantly from 0% to 2.8% (P 
= 0.03).  Similarly, non-sensitive oxytetracycline and tulathromycin isolates in calves increased 
from 0.5% to 3.7% (P =0.04) and 0% to 3.2% (P = 0.01), respectively. RANCH calves also had 
significant increases in non-sensitive P. multocida from the first to the second test.  From 0.4% 
to 9.0% in the case of florfenicol (P < 0.001), from 0.4% to 10.0% for oxytetracycline (P < 0.001), 
from 1.8% to 14.3% for tilmicosin (P < 0.001), and from 0.4% to 9.7% for tulathromycin (P < 
0.001). 
 
Finally, looking at antimicrobial sensitivity for H. somni isolates, all of the isolates were sensitive 
to chlortetracycline and florfenicol on the first and second tests for AUCT and RANCH calves 
(Table 3.5). In AUCT calves on the first test, all the H. somni isolates were sensitive to 
oxytetracycline, tilmicosin, and tulathromycin. However, by the second test, 11.5% of calves 
had H. somni isolates that were not sensitive to oxytetracycline (P < 0.001), 9.7% of calves were 
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not sensitive to tilmicosin (P < 0.001), and 9.2% were not sensitive to tulathromycin (P < 0.001). 
In the RANCH calves on the first test, all the H. somni isolates were sensitive to oxytetracycline, 
tilmicosin, or tulathromycin. By the second test, there was an increase in calves with non-
sensitive H. somni isolates to 0.7% for oxytetracycline, tilmicosin and tulathromycin.  This 
increase was not significant. 
 
3.4.3 Comparison of antimicrobial sensitivity of M. haemolytica, P. multocida, and H. somni 
isolates on arrival at the feedlot (first test). 
There was a significantly higher prevalence of AUCT calves compared to RANCH calves with M. 
haemolytica isolates on the first test that were not sensitive to oxytetracycline (P =0.02) and 
tilmicosin (P = 0.01). When looking at tulathromycin, there was a significantly higher prevalence 
of RANCH calves with non-sensitive M. haemolytica isolates than AUCT calves (P =0.04) (Table 
3.6). For both P. multocida and H. somni, there were not any significant differences in isolates 
or calves that were not sensitive to antimicrobials in the first test between the AUCT and 
RANCH calves. (Table 3.7 and Table 3.8). 
 
3.4.4 Health outcomes in AUCT calves versus RANCH calves 
The AUCT calves had significantly higher treatment risk for BRD at 14.4% compared to 9.0% in 
the RANCH calves (P = 0.043; Table 3.9). There was no significant difference in mortality risk 




3.4.5 Effect of treatment for BRD on antimicrobial sensitivity 
Cattle that had been treated for BRD were more likely to have isolates of P. multocida resistant 
to spectinomycin(odds ratio (OR): 3.09, 95% CI:1.09 to 8.75, P=0.034) and tilmicosin (OR: 3.27, 
95% CI: 1.17 to 9.13, P=0.024) on the second test. Cattle that had been treated for BRD were 
more likely to have isolates of H. somni resistant to oxytetracycline (OR: 3.95, 95% CI: 1.13 to 
13.8, P=0.032), tilmicosin (OR: 5.33, 95% CI: 1.51 to 18.8, P=0.009) and tulathromycin (OR: 3.86, 
95% CI: 1.12 to 13.2, P=0.032) on the second test (Table 3.10).  
 
Where the interaction between treatment for BRD and source of cattle (AUCT or RANCH) was 
significant, treated AUCT calves were more likely to have P. multocida resistant to florfenicol on 
the second test (OR: 28.0, 95% CI: 3.56 to 220, P=0.002) compared to untreated AUCT calves. 
Similarly, treated AUCT calves were more likely to have P. multocida resistant to oxytetracycline 
on the second test (OR: 13.3, 95% CI: 2.17 to 81.9, P=0.005) and P. multocida resistant to 
tulathromycin on the second test (OR: 18.2, 95% CI: 2.72 to 122, P=0.003) compared to 
untreated AUCT calves (Table 3.11). Treatment for BRD did not have these same effects in 
RANCH calves. 
 
3.4.6 Effect of positive isolates on treatment for BRD and death 
Calves that had positive isolates for H. somni on the first test were less likely to be treated for 
BRD (odds ratio (OR): 0.41, 95% CI: 0.20 to 0.86, P=0.019) than calves with negative isolates for 




In the unconditional analysis, there was a trend towards higher mortality in AUCT calves that 
had positive isolates for M. haemolytica on the first test (OR: 3.74, 95% CI: 0.95 to 14.8, 
P=0.06).  However, in the final multivariable analysis including source the association between 
positive M. haemolytica isolates on the first test and death was not significant (OR: 2.07, 95% 
CI: 0.74 to 5.83, P=0.17).  
 
3.5 Discussion 
To the author’s knowledge, this is the first study to look specifically at prevalence of BRD 
pathogens and antimicrobial sensitivity in ranch-raised calves compared to auction market-
derived calves. Most of the information in the literature looks at auction market derived 
cattle71,141,142. One of the objectives of this study was to determine the effects of mixing cattle 
on the prevalence of BRD pathogens isolated and the antimicrobial sensitivity of those 
pathogens.   
 
At 39.5%, this study had a higher prevalence of M. haemolytica isolates in auction market 
calves on arrival than has been found in previous studies, where prevalence ranged from 13% 
to 30%94,137,143,144. At 29.7%, the prevalence of M. haemolytica isolates for RANCH calves closely 
agreed with what has been found in auction market calves in other studies. The culture 
prevalence for M. haemolytica after calves have been in the feedlot for a period of time varied 
from 19% to 28% in other studies94,137,143,144, closely agreeing with the findings of this study for 
AUCT and RANCH calves. The significant decrease in M. haemolytica culture prevalence for 
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both AUCT and RANCH calves in the current study is not a consistent finding in other 
studies94,137. One reason for this could be the timing of the second sample collection. 
Particularly in the RANCH calves, the sampled were collected farther along in the feeding 
period at an average of 153 days. Other studies have shown that isolation rates of M. 
haemolytica are higher when the animal is affected with BRD, which is typically earlier in the 
feeding period94,144. The RANCH calves having second samples taken later in the feeding period 
than the AUCT calves is certainly a possibly source of bias in the trial and may have affected the 
results.  
 
For P. multocida isolates, there was a prevalence of 28.1% on arrival for AUCT calves, agreeing 
with other studies reporting 28%137 and 25%144. The culture prevalence of P. multocida in the 
RANCH calves on arrival in the current study is much higher at 60.0%. The reason for this is not 
clear. The RANCH calves in this study had no previous exposure to calves or cows outside of 
their herd prior to entry into the feedlot.  P. multocida culture prevalence did not change 
significantly from the first to the second test in AUCT cattle. In the RANCH cattle, P. multocida 
culture prevalence dropped significantly to 43.4% on the second test. This is consistent with a 
previous study from Saskatchewan in auction market derived calves137, but another study from 
Oklahoma showed a significant increase in P. multocida isolates in cattle during the feeding 
period144. 
 
A similar pattern was observed for H. somni isolates on the first test. For AUCT calves on arrival, 
H. somni culture prevalence at 14.8% was similar to another study reporting 9%137. Again, the 
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RANCH calves had significantly higher culture prevalence of H. somni than the AUCT calves on 
arrival at 38.7%. The AUCT calves had a significant increase in H. somni isolates to 30.4% at the 
time of the second test, similar to the previously mentioned study from Saskatchewan137. The 
prevalence of H. somni isolates decreased significantly in the RANCH calves to 6.1%. Again, the 
reason for this is not clear. A limitation of this study is that all the RANCH samples came from a 
single source. It is possible that the ranch calves selected for the study are not representative of 
calves on other ranches, and that if we had included samples from other ranch raised calves, 
the isolation rates of P. multocida and H. somni would have been different. 
 
The source of the calves, whether auction market derived or direct from the ranch, seems to 
have an effect on the risk of isolating BRD bacteria from DNS. It was not expected that the 
RANCH calves would have higher prevalence on the first test of P. multocida and H. somni 
isolates than the AUCT calves. Stroebel et al. showed that spending 24 hours in an auction 
market did not increase the rates of these same respiratory pathogens being isolated from 
calves, and those authors suggested that BRD pathogens are not very transmissible between 
calves142. It is possible the herd where the RANCH calves came from has a high amount of BRD 
pathogens circulating within the herd.  This herd had the same ownership as the feedlot.  The 
cow herd does not stay in the feedlot for an extended amount of time but it does have some 





Antimicrobial resistance in M. haemolytica samples of auction market derived calves on arrival 
at the feedlot is still relatively uncommon. M. haemolytica most commonly has resistance to 
tetracyclines, with studies showing 3% to 5% of M. haemolytica isolates resistant in auction 
market calves on arrival107,145. The current study had 26.7% of M. haemolytica isolates in AUCT 
calves not sensitive to oxytetracycline on arrival. That is much higher than what is reported in 
other studies. It could be that the prevalence of resistant bacteria is increasing over time, or 
that the cattle sampled had been previously treated with tetracyclines.  Interestingly, the 
RANCH calves had 20.3% of M. haemolytica isolates not sensitive to oxytetracycline, higher 
than you might expect in calves that had not received antimicrobials prior to arrival at the 
feedlot. Many studies have looked at macrolide resistance in beef cattle arriving at a feedlot, 
particularly because this class of antimicrobial is used extensively for metaphylaxis. M. 
haemolytica resistant to tilmicosin in calves on arrival is uncommon, reported at ≤1% in three 
studies107,141,145. Two more recent studies on cattle in the United States have reported higher 
levels of resistance to tilmicosin, in the 19-20% range101,131, on arrival to the feedlot in small 
groups. The current study found 27.6% of M. haemolytica samples in AUCT calves and 19% in 
RANCH calves were not sensitive to tilmicosin, again an increase over previous work. 
 
Many studies have shown an increase in antimicrobial resistance after cattle have been in the 
feedlot for a period of time, although results can vary significantly. A recent Canadian study 
showed a significant increase in resistance of 4 to 28% to macrolides after 90 days in the 
feedlot137, and other studies have shown resistance to macrolides approaching 100% after only 
7-14 days in the feedlot101,135. In the current study, the AUCT calves did show resistance 
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increase significantly in M. haemolytica isolates while the cattle were in the feedlot to 
tulathromycin, but not to the other antimicrobials. Interestingly, the resistance pattern in the 
RANCH calves was the opposite. The prevalence of calves with M. haemolytica isolates not 
sensitive on the second sample was significantly less for oxytetracycline, tilmicosin, and 
tulathromycin. One possible reason for this is the longer time period between samples for 
RANCH calves compared to AUCT calves. However, this pattern was only observed in M. 
haemolytica isolates, not in P. multocida or H. somni isolates. The authors could not find any 
previous work demonstrating this pattern so it may warrant further investigation. Most 
research suggests steadily increasing prevalence of resistance in M. haemolytica isolates90,97, 
which is certainly cause for concern.  
 
There has been limited research into resistant P. multocida on arrival in DNS, with most of the 
research looking at animals that have BRD already. One relevant study by Ericksen et al. found 
less than 2% of P. multocida samples were not sensitive to antimicrobials on arrival at the 
feedlot141, which is similar to our findings. The one exception in the current study is tilmicosin, 
which had 6.1% and 4.0% non-sensitive P. multocida in AUCT and RANCH calves, respectively. 
With no prior exposure to this antimicrobial in the RANCH calves, it is not clear why this would 
be the case. Both AUCT and RANCH calves had significant increases in P. multocida resistant to 
florfenicol, oxytetracycline, spectinomycin, and tulathromycin on the second test. The 
previously mentioned study by Ericksen et al. did not find this marked increase in resistant P. 
multocida in cattle on feed141. However, in studies looking at P. multocida in animals sick or 
dead from BRD, there is a very high prevalence of resistance to oxytetracycline, tulathromycin, 
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tilmicosin, and florfenicol97,98. The finding in the current study that animals that had been 
treated for BRD were more likely to have resistant P. multocida, along with the previously 
mentioned studies, would suggest that treatment is associated with a significantly increased 
risk of resistant P. multocida. 
 
Similar to P. multocida, most of the research into antimicrobial resistance in H. somni has been 
done on animals that are sick or dead due to BRD, not DNS on arrival. Again, the most relevant 
study was done by Ericksen et al. where they found 42% of H. somni samples were not sensitive 
to tilmicosin and 38% were not sensitive to tulathromycin on arrival141. After 90 days, similar 
prevalence of resistance persisted with 45% of samples not sensitive to tilmicosin and 43% not 
sensitive to tulathromycin. The current study did not find such substantial resistance on arrival, 
although the number of non-sensitive samples increased significantly at the time of second 
sampling for the AUCT calves, but not the RANCH calves. The current study also found high 
levels of resistance in cattle treated for BRD, suggesting that treatment leads to increased 
resistance of BRD pathogens90,97,98 . 
 
Treatment for BRD was significantly higher in AUCT cattle than RANCH cattle. Step et al. found 
similar results71. The finding that a positive H. somni isolate was associated with a significantly 
lower risk of being treated for BRD is interesting and not found elsewhere in the literature. 
There has been extensive research into the nasopharyngeal microbiota of calves in the first few 
weeks after arrival at the feedlot. Principally those studies have shown that the bacterial 
population undergoes substantive change in that time period, often moving to predominately 
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Mycoplasma sp.142,146. The current study did not find an association between positive isolates 
of M. haemolytica in DNS on arrival at the feedlot and later treatment for BRD. Other studies 
agree with this finding, with M. haemolytica only being isolated in increasing numbers just 
before treatment for BRD145, or at the time of treatment144. 
 
Similar to the current study, both Noyes et al. and Lamm et al. did not find an association 
between treatment with antimicrobials and subsequent resistance to antimicrobials in M. 
haemolytica94,147. However, Noyes et al. did show that calves were more likely to have M. 
haemolytica resistant to multiple antimicrobials when cattle in the same pen had been treated 
with antimicrobials94. Dedonder et al. found there was not a significant difference between 
calves mass medicated with gamithromycin and calves given saline on arrival in regards to the 
likelihood of culturing a resistant isolate of M. haemolytica or P. multocida148. In contrast, other 
studies have shown resistance to antimicrobials, sometimes as high as 100% resistance, in 
cattle treated metaphylatically97,101,135. The feedlot’s protocol was to use enrofloxacin for the 
first treatment for BRD in an individual calf and florfenicol for the second treatment. It is 
important to note that the statistical analysis did not differentiate if calves were treated once 
or twice. There was no association between treatment for BRD and resistance to enrofloxacin in 
any of the BRD pathogens, although resistance to enrofloxacin was very low. There was a 
significant association between treatment for BRD and P. multocida not sensitive to florfenicol 
on the second test in AUCT cattle. Treatment for BRD was also associated with P. multocida and 
H. somni resistant to macrolides and oxytetracycline. Klima et al. and Michael et al. have shown 
that resistance genes for macrolides and tetracyclines can be present alone or they can be 
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grouped together95,110. These studies also showed that resistance genes are part of the 
integrative and conjugative element that can travel across genus boundaries and into P. 
multocida and M. haemolytica. M. haemolytica, P. multocida, and H. somni possess integrative 
conjugative elements that can confer resistance for up to seven different antimicrobial 
classes95. This may explain the resistance observed to macrolides and tetracyclines in treated 
animals when the treatment was not with those antimicrobials.  
 
3.6 Conclusion 
This study showed a significant difference between the prevalence of BRD bacteria on DNS in 
auction market derived cattle versus cattle from a single source. Although it might be 
reasonably expected that the BRD pathogens examined in this study would be less prevalent in 
single source calves, this was not the case. However, morbidity in auction market calves was 
significantly higher. This would suggest that the prevalence of BRD pathogens on DNS on arrival 
is not necessarily associated with morbidity. Other factors such as the stress of mixing and 
reestablishing a social dominance hierarchy could be more significant and is an area of further 
research. 
 
Overall, the levels of antimicrobial resistance in this study were high when compared to 
previous studies. These results agree with other recent studies that show a trend towards 
increasing antimicrobial resistance. The finding of decreasing resistance only in RANCH calves 
that had M. haemolytica isolated on the second test is interesting and should be investigated in 
the future.  Another interesting finding that should be examined more closely is that calves 
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with positive isolates for H. somni on the first test were less likely to be treated for BRD than 
calves with negative isolates for H. somni. There has been more research recently into the 
nasopharyngeal microbiome that may help to explain how different bacterial populations are 
either harmful or protective in cases of BRD146. 
 
 Animals that are treated for BRD showing increased antimicrobial resistance in P. multocida 
and H. somni isolates is not surprising, but a helpful piece of information. It is also interesting 
that this pattern is not observed with M. haemolytica. This study shows that antimicrobial 
resistance in BRD pathogens is still a concern for the beef cattle industry, and that further 
research into non-medicinal prevention approaches such as altering cattle procurement 





Table 3.1 Comparison of positive isolates on DNS for each BRD pathogen at first test on arrival 
at the feedlot between auction market derived and ranch raised calves.   
 Auction Market Calves 
n=299 (%) 
Ranch Raised Calves 
n=300 (%) 
P-value 
M. haemolytica positive isolates 39.5% 29.7% 0.013 
P. multocida positive isolates 28.1% 60.0% <0.001 
H. somni positive isolates 14.8% 38.7% <0.001 
 
Table 3.2 Positive isolates on DNS in auction market and ranch raised calves for each of the BRD 
pathogens; M. haemolytica, P. multocida and H. somni, both on arrival at the feedlot (first test) 
and later on in the feeding period (second test), looking at matched pairs only. 
M. haemolytica results Positive M. haemolytica 
isolates on 1st Test (%) 
Positive M. haemolytica 
isolates on 2nd Test (%) 
P-value 
Auction Market Calves (n=217) 37.8% 20.3% <0.001 
Ranch Raised Calves (n=279) 29.4% 20.4% 0.01 
    
P. multocida results Positive P. multocida 
isolates on 1st Test (%) 
Positive P. multocida 
isolates on 2nd Test (%) 
 
Auction Market Calves (n=217) 30.9% 23.5% 0.08 
Ranch Raised Calves (n=279) 60.0% 43.4% <0.001 
    
H. somni results Positive H. somni 
isolates on 1st Test (%) 
Positive H. somni 
isolates on 2nd Test (%) 
 
Auction Market Calves (n=217) 17.1% 30.4% 0.001 














Table 3.3 Prevalence of M. haemolytica isolates and calves matched (first test to second test) 
not sensitive to antimicrobials on arrival at the feedlot (first test) and later on in the feeding 
























sensitive on 1st 






sensitive on 2nd 








Ampicillin 0% 0% 0% 0% - 
Ceftiofur 0% 0% 0% 0% - 
Chlortetracycline 1.7% 11.4% 0.9% 2.3% 0.45 
Danofloxacin 0% 0% 0% 0% - 
Enrofloxacin 0% 0% 0% 0% - 
Florfenicol 0% 0% 0% 0% - 
Gentamycin 0% 0% 0% 0% - 
Neomycin 26.7% 52.3% 12.0% 10.6% 0.76 
Oxytetracycline 26.7% 52.3% 10.6% 10.6% 1.00 
Penicillin 1.7% 2.3% 0% 0.5% 1.00 
Spectinomycin 0% 0% 0% 0% - 
Tilmicosin 27.6% 50% 11.1% 10.1% 0.88 
Trimethoprim/Sulfa 0% 0% 0% 0% - 















2nd Test (%) 
(n=57) 
Prevalence of 
Calves with M. 
haemolytica 
Isolates Not 
Sensitive on 1st 
Test (%) (n=279) 
Prevalence of 
Calves with M. 
haemolytica 
Isolates Not 
Sensitive on 2nd 








Ampicillin 0% 0% 0% 0% - 
Ceftiofur 0% 0% 0% 0% - 
Chlortetracycline 5.1% 5.3% 1.4% 1.1% 1.00 
Danofloxacin 0% 0% 0% 0% - 
Enrofloxacin 1.3% 0% 0.4% 0% 1.00 
Florfenicol 0% 0% 0% 0% - 
Gentamycin 0% 0% 0% 0% - 
Neomycin 22.8% 10.5% 6.5% 2.2% 0.02 
Oxytetracycline 20.3% 1.8% 5.7% 0.4% <0.001 
Penicillin 0% 8.8% 0% 1.8% 0.06 
Spectinomycin 1.3% 0% 0.4% 0% 1.00 
Tilmicosin 19.0% 0% 5.4% 0% <0.001 
Trimethoprim/Sulfa 0% 0% 0% 0% - 
Tulathromycin 19.0% 0% 5.4% 0% <0.001 
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Table 3.4 Prevalence of P. multocida isolates and calves matched (first test to second test) not 
sensitive to antimicrobials on arrival at the feedlot (first test) and later on in the feeding period 




















with P. multocida 
isolates not 
sensitive on 1st 
Test (%) (n=217) 
Prevalence of 
matched calves 
with P. multocida 
isolates not 
sensitive on 2nd 








Ampicillin 1.2% 5.9% 0.5% 1.4% 0.63 
Ceftiofur 0% 0% 0% 0% - 
Chlortetracycline 0% 0% 0% 0% - 
Danofloxacin 0% 0% 0% 0% - 
Enrofloxacin 0% 0% 0% 0% - 
Florfenicol 0% 11.8% 0% 2.8% 0.03 
Gentamycin 17.1% 5.9% 4.2% 1.4% 0.15 
Neomycin 84.2% 88.2% 24.9% 20.7% 0.33 
Oxytetracycline 1.2% 15.7% 0.5% 3.7% 0.04 
Penicillin 0% 0% 0% 0% - 
Spectinomycin 1.2% 17.7% 0.5% 4.2% 0.03 
Tilmicosin 6.1% 17.7% 2.3% 4.2% 0.39 
Trimethoprim/Sulfa 0% 0% 0% 0% - 




















calves with P. 
multocida isolates 
Not Sensitive on 
1st Test (%) 
(n=279) 
Prevalence of 
calves with P. 
multocida isolates 
Not Sensitive on 









Ampicillin 0.6% 0% 0.4% 0% 1.00 
Ceftiofur 0% 0% 0% 0% - 
Chlortetracycline 1.1% 11.6% 0.4% 5.0% 0.001 
Danofloxacin 0.6% 0.8% 0.4% 0.4% 1.00 
Enrofloxacin 0% 0.8% 0% 0.4% 1.00 
Florfenicol 1.7% 20.7% 0.4% 9.0% <0.001 
Gentamycin 15.9% 5.8% 9.7% 2.5% <0.001 
Neomycin 93.2% 89.3% 53.8% 38.7% <0.001 
Oxytetracycline 1.7% 23.1% 0.4% 10.0% <0.001 
Penicillin 0% 0% 0% 0% - 
Spectinomycin 1.7% 20.7% 0.4% 9.0% <0.001 
Tilmicosin 4.0% 33.1% 1.8% 14.3% <0.001 
Trimethoprim/Sulfa 0% 0% 0% 0% - 
Tulathromycin 1.7% 22.3% 0.4% 9.7% <0.001 
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Table 3.5 Prevalence of H. somni isolates and calves not sensitive to antimicrobials on arrival at 
the feedlot (first test) and later on in the feeding period (second test) (samples classified as 













2nd Test (%) 
(n=66) 
Prevalence of 
calves with H. 
somni isolates 
Not Sensitive on 
1st Test (%) 
(n=217) 
Prevalence of 
calves with H. 
somni isolates 
Not Sensitive 









Ampicillin 2.3% 1.5% 0.5% 0.5% 1.00 
Ceftiofur 0% 0% 0% 0% - 
Chlortetracycline 0% 0% 0% 0% - 
Danofloxacin 0% 0% 0% 0% - 
Enrofloxacin 0% 0% 0% 0% - 
Florfenicol 0% 0% 0% 0% - 
Gentamycin 38.6% 54.6% 6.0% 16.6% <0.001 
Neomycin 86.4% 89.4% 14.3% 27.2% <0.001 
Oxytetracycline 0% 37.9% 0% 11.5% <0.001 
Penicillin 2.3% 1.5% 0.5% 0.5% 1.00 
Spectinomycin 0% 6.1% 0% 1.8% 0.13 
Tilmicosin 0% 31.8% 0% 9.7% <0.001 
Trimethoprim/Sulfa 4.6% 3.0% 0.9% 0.9% 1.00 













2nd Test (%) 
(n=17) 
Prevalence of 
calves with H. 
somni isolates 
Not Sensitive on 
1st Test (%) 
(n=279) 
Prevalence of 
calves with H. 
somni isolates 
Not Sensitive 









Ampicillin 0% 0% 0% 0% - 
Ceftiofur 0% 0% 0% 0% - 
Chlortetracycline 0% 0% 0% 0% - 
Danofloxacin 0% 0% 0% 0% - 
Enrofloxacin 0% 0% 0% 0% - 
Florfenicol 0% 0% 0% 0% - 
Gentamycin 30.4% 17.7% 10.8% 1.1% <0.001 
Neomycin 91.2% 100% 31.5% 6.1% <0.001 
Oxytetracycline 0% 11.8% 0% 0.7% 0.5 
Penicillin 0% 0% 0% 0% - 
Spectinomycin 0% 0% 0% 0% - 
Tilmicosin 0% 11.8% 0% 0.7% 0.5 
Trimethoprim/Sulfa 2.0% 0% 0.7% 0% 0.5 
Tulathromycin 0% 11.8% 0% 0.7% 0.5 
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Table 3.6 Prevalence of M. haemolytica isolates and calves not sensitive to antimicrobials on 

































Ampicillin 0% 0% - 0% 0% - 
Ceftiofur 0% 0% - 0% 0% - 
Chlortetracycline 1.7% 5.1% 0.23 0.7% 1.3% 0.69 
Danofloxacin 0% 0% - 0% 0% - 
Enrofloxacin 0% 1.3% 0.41 0% 0.33% 1.00 
Florfenicol 0% 0% - 0% 0% - 
Gentamycin 0% 0% - 0% 0% - 
Neomycin 26.7% 22.8% 0.62 10.4% 6.0% 0.05 
Oxytetracycline 26.7% 20.25% 0.31 10.4% 5.3% 0.02 
Penicillin 1.7% 0% 0.52 0.7% 0% 0.25 
Spectinomycin 0% 1.3% 0.42 0% 0.3% 1.00 
Tilmicosin 27.6% 19.0% 0.18 10.7% 5.0% 0.01 
Trimethoprim/Sulfa 0% 0% - 0% 0% - 
Tulathromycin 4.3% 19.0% 0.001 1.7% 5.0% 0.04 
 
Table 3.7 Prevalence of P. multocida isolates and calves not sensitive to antimicrobials on 





































Ampicillin 1.2% 0.6% 0.535 0.3% 0.3% 1.00 
Ceftiofur 0% 0% - 0% 0% - 
Chlortetracycline 0% 1.1% 1.00 0% 0.7% 0.50 
Danofloxacin 0% 0.6% 1.00 0% 0.3% 1.00 
Enrofloxacin 0% 0% - 0% 0% - 
Florfenicol 0% 1.7% 0.554 0% 1.0% 0.25 
Gentamycin 17.1% 15.9% 0.857 4.7% 9.3% 0.04 
Neomycin 84.2% 93.2% 0.039 23.1% 54.7% <0.001 
Oxytetracycline 1.2% 1.7% 1.00 0.3% 1.0% 0.62 
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Penicillin 0% 0% - 0% 0% - 
Spectinomycin 1.2% 1.7% 1.00 0.3% 1.0% 0.62 
Tilmicosin 6.1% 4.0% 0.528 1.7% 2.3% 0.77 
Trimethoprim/Sulfa 0% 0% - 0% 0% - 
Tulathromycin 0% 1.7% 0.554 0% 1.0% 0.25 
 
 
Table 3.8 Prevalence of H. somni isolates and calves not sensitive to antimicrobials on arrival at 



































Ampicillin 2.3% 0% 0.297 0.3% 0% 0.50 
Ceftiofur 0% 0% - 0% 0% - 
Chlortetracycline 0% 0% - 0% 0% - 
Danofloxacin 0% 0% - 0% 0% - 
Enrofloxacin 0% 0% - 0% 0% - 
Florfenicol 0% 0% - 0% 0% - 
Gentamycin 39.5% 30.4% 0.335 5.7% 10.3% 0.05 
Neomycin 86.1% 91.2% 0.378 12.4% 31.0% <0.001 
Oxytetracycline 0% 0% - 0% 0% - 
Penicillin 2.3% 0% 0.297 0.3% 0% 0.50 
Spectinomycin 0% 0% - 0% 0% - 
Tilmicosin 0% 0% - 0% 0% - 
Trimethoprim/Sulfa 4.7% 2.0% 0.582 0.7% 0.7% 1.00 
Tulathromycin 0% 0% - 0% 0% - 
 
Table 3.9 Comparison of health outcomes (treatment for BRD and crude mortality) in auction 
market derived and ranch raised calves. 
Health Variable Experimental Group RR (95% CI)  P-Value 
 Auction Derived Ranch Raised   
     
No. of Animals – First Test 299 300   
Treatment for BRD, % 14.4 9.0 1.6 (1.0-2.5) 0.043 
Crude Mortality, % 3.3 1.7 2.0 (0.7-5.8) 0.204 
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Table 3.10 Cattle that had been treated for Bovine Respiratory Disease had the following 
significant outcomes, where the interaction between source of cattle (auction market vs ranch) 






Outcome  Lower Upper  
     
P. multocida resistant to spectinomycin on 2nd test 3.09 1.09 8.75 0.034 
P. multocida resistant to tilmicosin on 2nd test 3.27 1.17 9.13 0.024 
H. somni resistant to oxytetracycline on 2nd test 3.95 1.13 13.8 0.032 
H. somni resistant to tilmicosin on 2nd test 5.33 1.51 18.8 0.009 
H. somni resistant to tulathromycin on 2nd test 3.86 1.12 13.2 0.032 
 
 
Table 3.11 Cattle that had been treated for Bovine Respiratory Disease had the following 
significant outcomes, where the interaction between source of cattle (auction market vs ranch) 






Outcome  Lower Upper  
     
P. multocida resistant to florfenicol on 2nd test     
Treated auction calves vs untreated auction calves 28.0 3.56 220 0.002 
Treated ranch calves vs untreated ranch calves 1.50 0.37 6.12 0.572 
P. multocida resistant to oxytetracycline on 2nd test     
Treated auction calves vs untreated auction calves 13.3 2.17 81.9 0.005 
Treated ranch calves vs untreated ranch calves 1.28 0.31 5.17 0.734 
P. multocida resistant to tulathromycin on 2nd test     
Treated auction calves vs untreated auction calves 18.2 2.72 122 0.003 









Objective, discussion, general conclusions and future research 
4.1 Objectives 
The overarching aim of this thesis was to better understand ways to prevent disease in cattle by 
looking at how biosecurity and cattle mixing impact health outcomes. In order to achieve this 
aim, two separate studies were conducted. The first, chapter 2, was a survey of biosecurity 
practices of beef cow-calf producers in western Canada. The survey looked at common 
biosecurity practices of cow-calf producers and the associations between those practices and 
common diseases that are a concern for producers, and the upstream owners of the calves 
such as feedlot operators. The purpose of this was to help inform the cow-calf industry about 
the biosecurity measures that are currently being used that are having a negative effect on 
animal health.  At the same time there is acknowledgment that total exclusion of pathogens is 
impossible in the beef sector. The second study, chapter 3, looked at how the source of cattle 
impacts both the prevalence and antimicrobial resistance of the common BRD pathogens M. 
haemolytica, P. multocida, and H. somni. As well, this study looked at treatment for BRD and 
mortality and their association with the prevalence and antimicrobial resistance of these BRD 
pathogens. The purpose of this second study was to better understand how the source of 
purchased cattle can affect the types of BRD pathogens that are seen in the feedlot and the 
impact this has on morbidity and mortality in the feedlot. Again, the aim of this study was to 





There have been many studies done around the world looking at the topic of biosecurity, in 
both the beef cattle industry and in other areas of animal agriculture. However, there has not 
been any done in Canada looking specifically at beef cattle. Chapter 2 found that many of the 
standard biosecurity practices that would be common in the swine and poultry sectors are not 
commonly practiced in the Canadian beef industry. Only 30% of producers kept new additions 
separate from the main herd and 30% vaccinated new additions. Mixing of cattle was common 
with 30% of producers using community pastures for grazing. These results are similar to 
results found in many other countries11,12,15,20. This would lead us to believe that biosecurity in 
beef cattle is impacted by how they are raised, the fact they graze pastures extensively, and 
that they are marketed and moved from farm-to-farm throughout their life. These 
characteristics of the beef industry appear to be part of the beef production system the world 
over.  
 
Chapter 2 also showed the significance of purchasing adult cattle in the spread of BRD and calf 
diarrhea. We expected to find that cow-calf herds primarily have problems with BRD when they 
purchase feeder cattle, which often have BRD, and problems with calf diarrhea when 
purchasing foster calves, which often have diarrhea due to failure transfer of passive immunity. 
Instead, the purchase of cows and bulls was shown to be significantly associated with these 
diseases. The other association identified was with community pasture. There have been other 
studies that have also shown that community pasture is associated with the spread of cattle 
disease54,120. Finally, not vaccinating new arrivals was associated with BRD outbreaks. 
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Vaccination of cattle has been shown many times to reduce BRD70,71,133,149, so we would expect 
that not vaccinating would increase the occurrence of BRD outbreaks.  
 
A limitation of the study in Chapter 2 is that as it is a cross-sectional survey so we can only 
establish associations, not causation. Further research, such as using a case-control study or 
clinical trial, would be required to try and establish causation of practices such as the purchase 
of cows and use of community pasture. Another limitation is that in looking at only 81 
producers across western Canada, there is the potential that those producers are not 
representative of the industry as a whole. However, this study does provide a good basis for 
biosecurity practices in cow-calf herds in western Canada, as well as providing some areas 
where improvements can be made to reduce disease.  
 
Most studies on antimicrobial resistance have looked at cattle that are sick or have died due to 
BRD90,93,97. More recently, there have been studies looking at antimicrobial resistance on arrival 
and later on in the feeding period in groups of cattle regardless of disease state135,136,141. 
However, those studies have been on auction market cattle, not single source or ranch raised 
cattle. Chapter 3 looked at the prevalence of BRD pathogens and antimicrobial resistance 
comparing cattle that have been mixed (auction market cattle) to cattle from a single source. 
Overall, the prevalence of BRD pathogens isolated in this study was high when compared to 
other studies. Interestingly, the RANCH cattle had higher prevalence of both P. multocida and 
H. somni on arrival than the AUCT cattle, but lower prevalence of M. haemolytica. All of the 
RANCH cattle came from a single source, so it is not clear if the high prevalence of P. multocida 
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and H. somni is unique to the cattle of this ranch or if this is something that is common when 
cattle are not mixed. Stroebel et al. showed that 24 hours in an auction mart does not increase 
the rates of these respiratory pathogens being cultured in calves and that the BRD pathogens 
are not very transmissible between calves142. Because the calves from this herd had not been 
exposed to other cattle prior to sampling, we would assume transmission of the BRD pathogens 
was from the adult cows and bulls in the herd. This provides an interesting connection with 
Chapter 2, where the study demonstrated that introducing adult cows and bulls increased the 
odds of having a BRD outbreak in a herd. An area of further study would be to better 
understand how these pathogens transmit from the cows to the calves, as well as possible ways 
to decrease that transmission to reduce BRD pathogens in those calves. 
 
Chapter 3 also agreed with a trend seen in other studies showing increasing antimicrobial 
resistance in recent years90,97,135,136,141. The study added to that knowledge by showing some 
differences between auction market calves and single source calves. One interesting finding 
was that the RANCH calves had substantial levels of resistance to oxytetracycline, tilmicosin, 
and tulathromycin in M. haemolytica on arrival. Because we know the herd the RANCH calves 
came from, we can be reasonably certain that these calves had not been treated with 
antimicrobials prior to this testing.  This demonstrates that resistant M. haemolytica can 
transmit to calves and does not require exposure to antimicrobials for that resistance to 
develop. This is an area where further research could study how that transmission occurs and 
investigate methods to prevent that transmission. In both the AUCT calves and RANCH calves, 
antimicrobial resistance increased from the first to the second test. The only exception was 
101  
  
with M. haemolytica in the RANCH calves, where the amount of antimicrobial resistance 
decreased significantly over the feeding period. The AUCT calves showed an increase in 
antimicrobial resistance. This is an area for further research to see if this repeatable, and if so, 
to investigate the mechanism. These results also highlight another potential limitation of the 
study, which is the difference in time between the first and second samples in the AUCT calves 
and the RANCH calves. With the RANCH calves being sampled at an average of 153 days on feed 
versus 76 days for the AUCT calves this may explain some of the difference in antimicrobial 
resistance patterns. 
 
Another finding in Chapter 3 was that isolation of M. haemolytica on arrival did not appear to 
be associated with treatment for BRD; however, isolation of H. somni on arrival was associated 
with a decreased odds of requiring treatment for BRD. This research does seem to show that 
the type of BRD pathogens isolated impacts subsequent odds of treatment. This is an area of 
further research. Understanding what types of bacteria increase or decrease the odds of 
treatment could lead to an intervention or even methods to alter the microbiome to reduce 
BRD.  
 
Finally, Chapter 3 showed that treatment for BRD was associated with antimicrobial resistance 
in P. multocida and H. somni, but not in M. haemolytica. An area of further research would be 
to investigate why there is a difference between the BRD pathogens. The odds of resistance to 
florfenicol, oxytetracycline, and tulathromycin were much higher in treated AUCT calves than 
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RANCH calves. This may be due to previous exposure to these antimicrobials, although further 
investigation into why this would be the case is needed.  
4.3 General Conclusions 
The two studies helped answer some important questions for the beef industry. Chapter 2 
underlined the importance of caution when introducing new adult animals into a herd, such as 
breeding cows and bulls, and the risks posed by these introductions to the health of young 
calves. It also showed that communal grazing practices increases the risk of disease in young 
calves. Chapter 3 demonstrated that in AUCT calves the prevalence of M. haemolytica 
decreased over the feeding period and H. somni increased. In RANCH calves, the prevalence of 
M. haemolytica, P. multocida, and H. somni all decreased over the feeding period. Generally, 
there was an increase in resistant isolates over the feeding period, but surprisingly, there was a 
decrease in M. haemolytica isolates that were resistant to oxytetracycline, tilmicosin and 
tulathromycin. The source of calves affected the prevalence of BRD pathogens cultured on 
arrival – the prevalence of M. haemolytica was higher in AUCT calves and the prevalence of P. 
multocida and H. somni was higher in RANCH calves. The odds of a calf having P. multocida and 
H. somni resistant to multiple antibiotics was higher if they had been treated.  This study 
demonstrated the importance of reducing commingling in cattle when we are looking for ways 
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Western Canadian Cow-Calf Surveillance Network 
Survey 12 Biosecurity Practices in Cow-Calf Herds 
 
THIS QUESTIONNAIRE IS PART OF THE RESEARCH FOR THE BCRC- FUNDED 
DISEASE SURVEILLANCE NETWORK.   
 
 
Your participation is voluntary. All of your responses will be kept confidential. Return 
of our questionnaire by mail, will indicate your consent to participate in the survey 
and have your responses summarized in the final report. 
 
• Please answer each question in the questionnaire.  
 
• Please add any comments you may wish to make at the end of the questionnaire. 
 
• Please return the questionnaire in the provided stamped envelope. 
 
• Pages have questions both sides 
 
• Please send back each page of the questionnaire 
 
• Answer each question as best as you can. If something else should have been 
asked or included, please write us a note to explain. 
 
 
Please enter your name: _______________________________ 
 
If you have any questions regarding the questionnaire, feel free to call: 
Dr. Trent Wennekamp; (780) 808-0099 
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Or e-mail twennekamp@lah.ca 
Western Canadian Cow-Calf Surveillance Network 
Survey 12 Biosecurity Practices in Cow-Calf Herds 
 
For all of the following questions: 
 
Please do not leave blank spaces.  Enter zero if no animals in that category 
 (or   not applicable if the question does not apply to you     or       
 not answered if you choose not to answer.) 
 
Please answer questions looking back over the previous 3 years. 
 
Biosecurity is: Those practices that prevent disease from entering, spreading or being 
released from livestock operations. 
 
This survey is concerned with how disease may enter into or come out of your cow calf 
operation, and the effect those diseases may have on your herd. 
 
1. Current inventory: How many of each type of animal do you have in your herd currently? 
 
Number of BULLS ________  
Number of MATURE COWS (Over 2 Years Old) ________  
Number of REPLACEMENT HEIFERS (Under 2 Years Old) ________  
Number of CALVES (Under 6 months of age) ________  
Number of FEEDER CALVES ________  







Table A.1 Other Animals on the Farm: Please circle yes or no if you have other animals on 
the farm. Also, please give us the number of other animals, and if they have contact with 
your Beef Cattle. (Contact would be fence line contact, or mingling with the cattle). 
 
 Animals on farm? If Yes, How many? Contact with Cattle? 
Dairy Cattle  YES     or      NO  YES     or      NO 
Horses YES     or      NO  YES     or      NO 
Goats YES     or      NO  YES     or      NO 
Sheep YES     or      NO  YES     or      NO 
Elk YES     or      NO  YES     or      NO 
Bison YES     or      NO  YES     or      NO 







YES     or      NO 
 








YES     or      NO 
 





2. Purchased Animals: Please look back over the last 3 years (since 2014) as well as 2017 
and tell us how many head of each animal type you purchased or added into your cow calf 
herd. 
Under each year please fill in approximately the number of animals of each type you have 
added into the herd: 
 
For example, the table below shows that in each year over the last 3 years as well as this year 
Producer A purchased 5 bulls and 30 mature cows: 
 2017 2016 2015 2014 
Bulls 5 5 5 5 
Mature Cows 30 30 30 30 
 
Table A.2 
 2017 2016 2015 2014 
Bulls     
Mature Cows (Over 2 Years Old)     
Heifers (4 months to 2 Years 
Old) 
    
Foster Calves (Under 30 days 
Old) 
    
Feeder Calves / Backgrounding 
/Grass Calves (Heifers and 
Steers) 
    
Other (please describe) 
___________________________ 






3. Please list in the table below the number of animals from each source which you 
PURCHASED cattle in the last 12 months. 
 
For example, in the table below Producer A purchased 5 bulls: 3 from a local purebred breeder 
and 2 from a bull sale. As well, he bought 30 mature cows: 20 from a sale at the auction market 
and 10 from a neighbor’s farm. 




0 3 2 
Mature Cows 20 10 0 
 
Table A.3: 
 Auction Market Another Farm Sale (ie. Bull 
Sale) 
Bulls    
Mature Cows (Over 2 Years Old)    
Heifers (4 months to  2 Years Old)    
Foster Calves (Under 30 days Old)    
Feeder Calves / Backgrounding /Grass 
Calves (Heifers and Steers) 
   
Other (Please Describe) 
______________________________________ 
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4. Please list in the table below the number of animals to each source you SOLD cattle in 
the last 12 months. 
For example, last fall Producer A sold 20 replacement heifers to a neighbor.  He also sold 50 
feeder heifers at the auction market.  
 Auction Market Another Farm Sale (ie. Bull 
Sale) 
Replacement Heifers (Under 2 Years 
Old) 
0 20 0 
Foster Calves (Under 30 Days Old)  0 0 0 
Feeder Heifers 50 0 0 
 
Table A.4: 
 Auction Market Another Farm Sale (ie. Bull 
Sale) 
Bulls    
Mature Cows (Over 2 Years Old)    
Replacement Heifers (Under 2 Years 
Old) 
   
Foster Calves (Under 30 Days Old)    
Feeder Heifers    
Feeder Steers    
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5. When you purchase or add new animals to the herd, do you keep them separate from the 
 rest of herd for a period of time?  
 
□Yes. For how long? ________ 
□ No 




6. When you purchase or add new animals to the herd, do you vaccinate them for any  
 diseases prior to adding them to the herd?  
 
□ Yes. What vaccine(s) do you give them? ________________________________________ 
□ No 
 
7. If you indicated above that you have purchased calves to feed in the last 3 years, describe 
the contact that these calves have with the cow herd (Select the highest level of contact 
even if it is for a brief part of the time period) (please select ONE)  
□ Commingle 
□ Fence line contact 
□ Same farm but no contact 
□ Fed on different farm 
□ Other (please describe) _______________________________________________________ 
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8. Do you ask about disease history when you are buying cattle? For example, do you ask if 
a farm has had a history of Johne’s disease prior to buying replacement heifers? (please 
select ONE)  
□Yes. What diseases do you inquire about? ________________________________ 
□ No 




9. Do you ask about vaccination history when you are buying cattle? (please select ONE)  
□Yes 
□ No 




10. Have you done any custom feeding on your farm in the last 3 years? (please select ONE)  
□Yes □ No 
 
11. Have you done any custom calving on your farm in the last 3 years? (please select ONE)  
□Yes □ No 
 
 





12. Are you using a community pasture for summer grazing in the 2017 grazing season? 
(please select ONE)  
□Yes □ No  
If YES please answer the next two questions 
13.  How many of each animal type do you send to community pasture? 
 
Number of BULLS ________  
Number of COWS ________  
Number of REPLACEMENT HEIFERS ________  
Number of CALVES ________  
 
14.  What will be the total number of other herds that your herd was exposed to during 
communal grazing in 2017? 
 
                      Enter number of herds (If you’re not sure, just give an approximate number.) 
 
15.  Have you, or will you, take some of your cattle to shows during the 2017 year? (please 
select ONE)  
□Yes □ No  
If YES please answer the next two questions 
16. How many shows do you go to in an average year? 
 
                      Enter number of shows 
 
17. Have you ever had to treat an animal (i.e. for pneumonia) that was taken to a show? 
(please select ONE)  
 □Yes □ No 
 
18. Did you have a bull sale on your farm in 2017? (please select ONE)  
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 □Yes □ No 
 
19. If yes, do other producers sell bulls in your sale? (Please select ONE) 
 
□ Yes. How many other producers sell bulls in your sale? ________________________ 
□ No 
□ Not Applicable 
 
20. Have you leased bulls or shared bulls during a single breeding season from another 
producer in the last 3 years? (please select ONE)  








Managing People, Equipment and Vehicles. 
 
21. Do you restrict the access of people from other farms to your cattle? (please select ONE)  
□Yes 
□ No 




22. Have you had anyone from a country other than Canada visit your farm in the last year? 
(Please select ONE) 
 
□ Yes. What countries? ________________________________________________ 
□ No 
 
23. Do you use the same equipment (i.e. tractor, front end loader) for manure handling and 
feeding cattle? (please select ONE)  
 □Yes  □ No 
 
24. If yes, do you clean and disinfect your front end loader after handling manure? (please 
select ONE)  






25. How often are the following items cleaned and/or disinfected on your farm? (Please check 











Never Item Not 
Used 
Cattle Trailer       
Calving Tools (ie. Chains, 
jack) 
      
Boots       
Clothing       
Tube Feeder for Calves       
All Terrain Vehicle       
Veterinary Supplies (ie. 
Multi-use Syringes) 
      
Calving Barn       
Front End Loader / 
Tractor 




Managing Animal Health Practices. 
 
26. Do you have a working relationship with a veterinarian or veterinary practice? (Please 
select ONE) 
 







27. What services does your veterinarian typically provide to you in a year? (Please select ALL 
THAT APPLY) 
 
□ Pregnancy diagnosis 
□ Bull testing 
□ Body condition scoring 
□ Routine post mortems of dead animals 
□ Trichomoniasis testing of bulls 
□ Treatment of sick animals when necessary 
□ Assisting with calving difficulty: C-section/Hard Pulls 
□ Advice regarding vaccines 
□ Treatment advice 
□ Biosecurity advice 
□ Disease prevention advice 
□ Written vaccine protocols or standard operating procedures 
□ Written treatment protocols or standard operating procedures 
□ Written biosecurity protocols or standard operating procedures 
□ Assistance with Quality Assurance Programs 
□ Marketing advice 
□ Staff, employee or family member training 
□ Feed analysis or ration formulation 
□ Advice regarding nutrition 




Biosecurity Within Your Herd 
 
 
Please answer the following questions based on the following scenarios: 
28. “One day in early June after the cows have gone to summer pasture, you find a cow that 
had her third calf that year is looking much thinner than the other cows.  She looks like 
she may have had some diarrhea as well.  You have had Johne’s disease in your herd in 
the past and you suspect this cow may have Johne’s.”  What do you do? (Please check 
those that apply) 
□ Separate the cow from the rest of the herd and observe 
□ Remove calf to put on another cow and cull the sick cow. 
□ Leave as is until fall and cull cow at that time.  
□ Ensure calf is recorded and is NOT kept in herd as a replacement. 
□ Do nothing and see how cow progresses. 
□ Make a plan to remove Johne’s in your herd with your veterinarian. 
 
29. “You find a 2 week old calf in the calving area with severe diarrhea (scours). The calf is 
able to stand and suck, but is definitely weakened.”  What do you do? (Please check those 
that apply) 
□ Bring the cow and calf into the barn to treat the calf. 
□ Treat calf out in calving area and leave the calf there. 
□ Separate cow and calf from herd for at least a few days. 




Disease Within Your Herd 
 
30. Have you had to treat an animal in your herd for the following diseases in the last 5 
years?  
How many OUTBREAKS of the following infectious disease have you had your herd in 
the last 5 years?  
For this survey we will define an OUTBREAK as a situation where you had to treat at 
least 10% of the group, or at least 10% were affected.  For example, last spring you 




Disease Treated Animal for this 
disease in last 5 years? 
(Please circle ONE) 
Had an Outbreak in 




Shipping Fever/Pneumonia YES    or    NO YES    or    NO  
Scours / Calf diarrhea YES    or    NO YES    or    NO  
Coccidiosis 
 
YES    or    NO YES    or    NO  
Infectious Bovine 
Rhinotracheitis (IBR) 
YES    or    NO YES    or    NO  
Bovine Viral Diarrhea (BVD) 
YES    or    NO YES    or    NO  
Pinkeye 
YES    or    NO YES    or    NO  
Footrot 
YES    or    NO YES    or    NO  
Trichomoniasis 
YES    or    NO YES    or    NO  
Vibriosis 





31. Have you had 5% or more of your herd abort their calves in a single calving season in the 
last 5 years? (Please select ONE) 
 
 □ Yes □No 
If YES please answer the next two questions 
32. How many times has this occurred in the past 5 years? 
 
                      Enter number of times 
 





34. Have you had Johne’s Disease diagnosed in your herd? (Please select ONE) 
 





Please RANK the following options in the order that best represents your management 
practices.  
Leave those you don’t consider blank.  (1 is the highest rank, i.e. the most important) 
35.  Rank all of the following factors that you would typically consider when deciding what 
ANTIMICROBIALS to use on your operation. 
 
____   Microbial cost 
____   Historical effectiveness  
____   Convenience (1 dose vs multiple doses)  
____   Route of administration (SC, IM, in feed, oral bolus, other) 
____   Withdrawal time 
____   Written treatment protocol from veterinarian  
____   Advertising or information from other information sources 
____   Advice from another producer 
____   Other (Please specify): ___________________________ 
____   Not applicable – I don’t use antimicrobials 
 







Thank you so much for taking the time to complete this survey.  
Your responses will provide valuable information to the 
Canadian beef industry!  
  
